CA2244049A1 - Bioactive coating with a low-friction surface - Google Patents
Bioactive coating with a low-friction surface Download PDFInfo
- Publication number
- CA2244049A1 CA2244049A1 CA 2244049 CA2244049A CA2244049A1 CA 2244049 A1 CA2244049 A1 CA 2244049A1 CA 2244049 CA2244049 CA 2244049 CA 2244049 A CA2244049 A CA 2244049A CA 2244049 A1 CA2244049 A1 CA 2244049A1
- Authority
- CA
- Canada
- Prior art keywords
- acid
- monomer
- sodium
- group
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000011248 coating agent Substances 0.000 title claims description 11
- 238000000576 coating method Methods 0.000 title claims description 11
- 230000000975 bioactive effect Effects 0.000 title description 5
- 239000000178 monomer Substances 0.000 claims abstract description 107
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 27
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 claims abstract description 22
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract description 21
- 229920001577 copolymer Polymers 0.000 claims abstract description 20
- 150000007942 carboxylates Chemical group 0.000 claims abstract description 19
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims abstract description 17
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 15
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims abstract description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims abstract description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229920002554 vinyl polymer Polymers 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 6
- 125000005670 ethenylalkyl group Chemical group 0.000 claims abstract description 5
- 241000208125 Nicotiana Species 0.000 claims abstract description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 4
- 229920000642 polymer Polymers 0.000 claims description 71
- -1 alkyl radical Chemical class 0.000 claims description 29
- 150000003254 radicals Chemical class 0.000 claims description 18
- 239000000758 substrate Substances 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- 229910001413 alkali metal ion Inorganic materials 0.000 claims description 6
- 229930195733 hydrocarbon Natural products 0.000 claims description 6
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical group COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000004215 Carbon black (E152) Substances 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 claims description 4
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 claims description 4
- JLIDVCMBCGBIEY-UHFFFAOYSA-N 1-penten-3-one Chemical compound CCC(=O)C=C JLIDVCMBCGBIEY-UHFFFAOYSA-N 0.000 claims description 4
- OLQFXOWPTQTLDP-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCO OLQFXOWPTQTLDP-UHFFFAOYSA-N 0.000 claims description 4
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 claims description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 4
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 claims description 4
- XFTALRAZSCGSKN-UHFFFAOYSA-M sodium;4-ethenylbenzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=C(C=C)C=C1 XFTALRAZSCGSKN-UHFFFAOYSA-M 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 4
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 claims description 4
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 claims description 4
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 claims description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 3
- 238000010528 free radical solution polymerization reaction Methods 0.000 claims description 3
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 2
- BZCOSCNPHJNQBP-UPHRSURJSA-N (z)-2,3-dihydroxybut-2-enedioic acid Chemical compound OC(=O)C(\O)=C(\O)C(O)=O BZCOSCNPHJNQBP-UPHRSURJSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 2
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 claims description 2
- ZMARGGQEAJXRFP-UHFFFAOYSA-N 1-hydroxypropan-2-yl 2-methylprop-2-enoate Chemical compound OCC(C)OC(=O)C(C)=C ZMARGGQEAJXRFP-UHFFFAOYSA-N 0.000 claims description 2
- UXYMHGCNVRUGNO-UHFFFAOYSA-N 1-hydroxypropan-2-yl prop-2-enoate Chemical compound OCC(C)OC(=O)C=C UXYMHGCNVRUGNO-UHFFFAOYSA-N 0.000 claims description 2
- RWXMAAYKJDQVTF-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl prop-2-enoate Chemical compound OCCOCCOC(=O)C=C RWXMAAYKJDQVTF-UHFFFAOYSA-N 0.000 claims description 2
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 claims description 2
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 claims description 2
- VLKXLWGYPOUERV-UHFFFAOYSA-N 2-[3-(oxiran-2-ylmethoxy)propoxymethyl]oxirane Chemical compound C1OC1COCCCOCC1CO1 VLKXLWGYPOUERV-UHFFFAOYSA-N 0.000 claims description 2
- VMSBGXAJJLPWKV-UHFFFAOYSA-N 2-ethenylbenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1C=C VMSBGXAJJLPWKV-UHFFFAOYSA-N 0.000 claims description 2
- XUDBVJCTLZTSDC-UHFFFAOYSA-N 2-ethenylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C=C XUDBVJCTLZTSDC-UHFFFAOYSA-N 0.000 claims description 2
- CFVWNXQPGQOHRJ-UHFFFAOYSA-N 2-methylpropyl prop-2-enoate Chemical compound CC(C)COC(=O)C=C CFVWNXQPGQOHRJ-UHFFFAOYSA-N 0.000 claims description 2
- JHUFGBSGINLPOW-UHFFFAOYSA-N 3-chloro-4-(trifluoromethoxy)benzoyl cyanide Chemical compound FC(F)(F)OC1=CC=C(C(=O)C#N)C=C1Cl JHUFGBSGINLPOW-UHFFFAOYSA-N 0.000 claims description 2
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 claims description 2
- WLPQGZNMXPKVBI-UHFFFAOYSA-N 4-ethenyl-2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(C=C)C=C1O WLPQGZNMXPKVBI-UHFFFAOYSA-N 0.000 claims description 2
- MAGFQRLKWCCTQJ-UHFFFAOYSA-N 4-ethenylbenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(C=C)C=C1 MAGFQRLKWCCTQJ-UHFFFAOYSA-N 0.000 claims description 2
- IRQWEODKXLDORP-UHFFFAOYSA-N 4-ethenylbenzoic acid Chemical compound OC(=O)C1=CC=C(C=C)C=C1 IRQWEODKXLDORP-UHFFFAOYSA-N 0.000 claims description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 2
- UMHJEEQLYBKSAN-UHFFFAOYSA-N Adipaldehyde Chemical compound O=CCCCCC=O UMHJEEQLYBKSAN-UHFFFAOYSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 2
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000005057 Hexamethylene diisocyanate Substances 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-O Methylammonium ion Chemical compound [NH3+]C BAVYZALUXZFZLV-UHFFFAOYSA-O 0.000 claims description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical class CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 claims description 2
- 229910004727 OSO3H Inorganic materials 0.000 claims description 2
- 229910006069 SO3H Inorganic materials 0.000 claims description 2
- 125000004018 acid anhydride group Chemical group 0.000 claims description 2
- PVEOYINWKBTPIZ-UHFFFAOYSA-N but-3-enoic acid Chemical compound OC(=O)CC=C PVEOYINWKBTPIZ-UHFFFAOYSA-N 0.000 claims description 2
- 235000004883 caffeic acid Nutrition 0.000 claims description 2
- 229940074360 caffeic acid Drugs 0.000 claims description 2
- 150000001244 carboxylic acid anhydrides Chemical group 0.000 claims description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 2
- 235000013985 cinnamic acid Nutrition 0.000 claims description 2
- 229930016911 cinnamic acid Natural products 0.000 claims description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 2
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 claims description 2
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 claims description 2
- NAPSCFZYZVSQHF-UHFFFAOYSA-N dimantine Chemical compound CCCCCCCCCCCCCCCCCCN(C)C NAPSCFZYZVSQHF-UHFFFAOYSA-N 0.000 claims description 2
- RBZSHMFYEVDBRR-UHFFFAOYSA-N dimethyl(octyl)azanium 4-ethenylbenzenesulfonate Chemical compound C=CC1=CC=C(C=C1)S(=O)(=O)[O-].C[NH+](CCCCCCCC)C RBZSHMFYEVDBRR-UHFFFAOYSA-N 0.000 claims description 2
- GPCYNSLPAPNYRW-UHFFFAOYSA-N dimethyl(octyl)azanium;2-ethenylbenzenesulfonate Chemical compound CCCCCCCC[NH+](C)C.[O-]S(=O)(=O)C1=CC=CC=C1C=C GPCYNSLPAPNYRW-UHFFFAOYSA-N 0.000 claims description 2
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 claims description 2
- VFNGKCDDZUSWLR-UHFFFAOYSA-N disulfuric acid Chemical compound OS(=O)(=O)OS(O)(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-N 0.000 claims description 2
- 238000007720 emulsion polymerization reaction Methods 0.000 claims description 2
- UYMKPFRHYYNDTL-UHFFFAOYSA-N ethenamine Chemical compound NC=C UYMKPFRHYYNDTL-UHFFFAOYSA-N 0.000 claims description 2
- PWHMFVALYNYYMZ-UHFFFAOYSA-N ethenyl phenylmethanesulfonate;sodium Chemical compound [Na].C=COS(=O)(=O)CC1=CC=CC=C1 PWHMFVALYNYYMZ-UHFFFAOYSA-N 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 239000001530 fumaric acid Substances 0.000 claims description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 claims description 2
- LDHQCZJRKDOVOX-IHWYPQMZSA-N isocrotonic acid Chemical compound C\C=C/C(O)=O LDHQCZJRKDOVOX-IHWYPQMZSA-N 0.000 claims description 2
- HNEGQIOMVPPMNR-NSCUHMNNSA-N mesaconic acid Chemical compound OC(=O)C(/C)=C/C(O)=O HNEGQIOMVPPMNR-NSCUHMNNSA-N 0.000 claims description 2
- 125000005394 methallyl group Chemical group 0.000 claims description 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 claims description 2
- HNEGQIOMVPPMNR-UHFFFAOYSA-N methylfumaric acid Natural products OC(=O)C(C)=CC(O)=O HNEGQIOMVPPMNR-UHFFFAOYSA-N 0.000 claims description 2
- UQKAOOAFEFCDGT-UHFFFAOYSA-N n,n-dimethyloctan-1-amine Chemical compound CCCCCCCCN(C)C UQKAOOAFEFCDGT-UHFFFAOYSA-N 0.000 claims description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 2
- HVAMZGADVCBITI-UHFFFAOYSA-N pent-4-enoic acid Chemical compound OC(=O)CCC=C HVAMZGADVCBITI-UHFFFAOYSA-N 0.000 claims description 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 2
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 claims description 2
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 claims description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 claims description 2
- 238000010526 radical polymerization reaction Methods 0.000 claims description 2
- XESUCHPMWXMNRV-UHFFFAOYSA-M sodium;2-ethenylbenzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=CC=C1C=C XESUCHPMWXMNRV-UHFFFAOYSA-M 0.000 claims description 2
- SZHIIIPPJJXYRY-UHFFFAOYSA-M sodium;2-methylprop-2-ene-1-sulfonate Chemical compound [Na+].CC(=C)CS([O-])(=O)=O SZHIIIPPJJXYRY-UHFFFAOYSA-M 0.000 claims description 2
- BWYYYTVSBPRQCN-UHFFFAOYSA-M sodium;ethenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C=C BWYYYTVSBPRQCN-UHFFFAOYSA-M 0.000 claims description 2
- USEWKBLLMCFAEJ-UHFFFAOYSA-M sodium;prop-2-enyl sulfate Chemical compound [Na+].[O-]S(=O)(=O)OCC=C USEWKBLLMCFAEJ-UHFFFAOYSA-M 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 2
- KUCOHFSKRZZVRO-UHFFFAOYSA-N terephthalaldehyde Chemical compound O=CC1=CC=C(C=O)C=C1 KUCOHFSKRZZVRO-UHFFFAOYSA-N 0.000 claims description 2
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 claims description 2
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical group CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 claims description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 claims 2
- MAGFQRLKWCCTQJ-UHFFFAOYSA-M 4-ethenylbenzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=C(C=C)C=C1 MAGFQRLKWCCTQJ-UHFFFAOYSA-M 0.000 claims 2
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- CGBYBGVMDAPUIH-ONEGZZNKSA-N (e)-2,3-dimethylbut-2-enedioic acid Chemical compound OC(=O)C(/C)=C(\C)C(O)=O CGBYBGVMDAPUIH-ONEGZZNKSA-N 0.000 claims 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims 1
- 239000005058 Isophorone diisocyanate Substances 0.000 claims 1
- PCSMJKASWLYICJ-UHFFFAOYSA-N Succinic aldehyde Chemical compound O=CCCC=O PCSMJKASWLYICJ-UHFFFAOYSA-N 0.000 claims 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 claims 1
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 claims 1
- WQQBLIFYNSRDDL-UHFFFAOYSA-N methoxyethene;prop-2-enoic acid Chemical compound COC=C.OC(=O)C=C WQQBLIFYNSRDDL-UHFFFAOYSA-N 0.000 claims 1
- CBXWGGFGZDVPNV-UHFFFAOYSA-N so4-so4 Chemical compound OS(O)(=O)=O.OS(O)(=O)=O CBXWGGFGZDVPNV-UHFFFAOYSA-N 0.000 claims 1
- NLVXSWCKKBEXTG-UHFFFAOYSA-N vinylsulfonic acid Chemical compound OS(=O)(=O)C=C NLVXSWCKKBEXTG-UHFFFAOYSA-N 0.000 claims 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 16
- 229920000307 polymer substrate Polymers 0.000 description 16
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- 229920000299 Nylon 12 Polymers 0.000 description 11
- 229920001688 coating polymer Polymers 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 230000019635 sulfation Effects 0.000 description 11
- 238000005670 sulfation reaction Methods 0.000 description 11
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 10
- 229910001415 sodium ion Inorganic materials 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 238000006116 polymerization reaction Methods 0.000 description 8
- 230000002378 acidificating effect Effects 0.000 description 7
- 125000003277 amino group Chemical group 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-YIDFTEPTSA-N IDOSE Chemical group OC[C@H]1OC(O)[C@@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-YIDFTEPTSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 238000010511 deprotection reaction Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 5
- 229920001228 polyisocyanate Polymers 0.000 description 5
- 239000005056 polyisocyanate Substances 0.000 description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 4
- 150000001733 carboxylic acid esters Chemical group 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- 229960002897 heparin Drugs 0.000 description 4
- 229920000669 heparin Polymers 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000005871 repellent Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000588747 Klebsiella pneumoniae Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000006359 acetalization reaction Methods 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 235000012209 glucono delta-lactone Nutrition 0.000 description 3
- 239000011261 inert gas Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000003747 Grignard reaction Methods 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 229920001744 Polyaldehyde Polymers 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- AYJRCSIUFZENHW-UHFFFAOYSA-L barium carbonate Chemical compound [Ba+2].[O-]C([O-])=O AYJRCSIUFZENHW-UHFFFAOYSA-L 0.000 description 2
- 229910001422 barium ion Inorganic materials 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000008199 coating composition Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- UZBQIPPOMKBLAS-UHFFFAOYSA-N diethylazanide Chemical compound CC[N-]CC UZBQIPPOMKBLAS-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 229950006191 gluconic acid Drugs 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical group 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 150000002763 monocarboxylic acids Chemical class 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N n-propyl alcohol Natural products CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 150000002972 pentoses Chemical class 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 238000006268 reductive amination reaction Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- MNCGMVDMOKPCSQ-UHFFFAOYSA-M sodium;2-phenylethenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C=CC1=CC=CC=C1 MNCGMVDMOKPCSQ-UHFFFAOYSA-M 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- FSDICPPKTWJUKY-ZZVYKPCYSA-N (2r,3s,4r,5r)-1-(4-ethenylphenyl)-2,3,4,5,6-pentahydroxyhexan-1-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)C1=CC=C(C=C)C=C1 FSDICPPKTWJUKY-ZZVYKPCYSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical class CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 1
- GZCGUPFRVQAUEE-UHFFFAOYSA-N 2,3,4,5,6-pentahydroxyhexanal Chemical compound OCC(O)C(O)C(O)C(O)C=O GZCGUPFRVQAUEE-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N 3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- UYJGSTWLKWDZHM-UHFFFAOYSA-N 3-(4-ethenylphenyl)pentane-1,1,1,2,2-pentol Chemical compound OC(O)(O)C(O)(O)C(CC)C1=CC=C(C=C)C=C1 UYJGSTWLKWDZHM-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241001631457 Cannula Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 229920000572 Nylon 6/12 Polymers 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 150000001241 acetals Chemical group 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 229940048053 acrylate Drugs 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005263 alkylenediamine group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical class [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- RPGLXOSMUNSOSY-UHFFFAOYSA-N bis(4-ethenylphenyl)methanone Chemical compound C1=CC(C=C)=CC=C1C(=O)C1=CC=C(C=C)C=C1 RPGLXOSMUNSOSY-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 238000006705 deacetalization reaction Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 125000000600 disaccharide group Chemical group 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 150000002118 epoxides Chemical group 0.000 description 1
- WCBBLESOBVCMFC-UHFFFAOYSA-N ethenesulfonic acid;sodium Chemical compound [Na].OS(=O)(=O)C=C WCBBLESOBVCMFC-UHFFFAOYSA-N 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 150000004678 hydrides Chemical group 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- IWCVDCOJSPWGRW-UHFFFAOYSA-M magnesium;benzene;chloride Chemical compound [Mg+2].[Cl-].C1=CC=[C-]C=C1 IWCVDCOJSPWGRW-UHFFFAOYSA-M 0.000 description 1
- JTXVECOSFMEWRK-UHFFFAOYSA-M magnesium;ethenylbenzene;chloride Chemical compound [Mg+2].[Cl-].C=CC1=CC=[C-]C=C1 JTXVECOSFMEWRK-UHFFFAOYSA-M 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- WHIVNJATOVLWBW-UHFFFAOYSA-N n-butan-2-ylidenehydroxylamine Chemical compound CCC(C)=NO WHIVNJATOVLWBW-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- UCUUFSAXZMGPGH-UHFFFAOYSA-N penta-1,4-dien-3-one Chemical class C=CC(=O)C=C UCUUFSAXZMGPGH-UHFFFAOYSA-N 0.000 description 1
- 229930193351 phorone Natural products 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920005906 polyester polyol Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000002130 sulfonic acid ester group Chemical group 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 238000010345 tape casting Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Paints Or Removers (AREA)
Abstract
Disclosed is a copolymer derived from monomers comprising: (A) maleic anhydride; (B) at least one vinyl alkyl ether having an alkyl radical of 1 to 6 carbon atoms; (C) at least one vinyl monomer containing a carboxyl or carboxylate group; and (D) at least one vinyl monomer containing a sulfuric acid, sulfate, sulfonic acid or sulfonate group. The copolymer is useful for the production of products for use in the fields of foodstuffs and tobacco, the water industry and bioengineering, hygiene provision and, in particular, medicine.
Description
Bioactive coatinq with a low-friction surface Field of the Invention The invention relates to polymers that may be used for coating substrates by covalent bonding. These polymers show certain bioactive properties on the basis of the presence of certain functional groups and furthermore are low-friction, i.e. have a remarkably low coefficient of friction when in a moistened (aqueous-moist) state. Important bioactive properties of polymers according to the invention are their bacteria-repellent properties and their good tolerability in contact with body fluids and tissue. Depending on the molar ratio of certain functional groups, the surfaces moreover are rendered cell proliferation-inhibiting or cell proliferation-promoting. The invention furthermore relates to articles having surfaces coated in this way.
Prior Art European Patent Publication 0 166 998 (corresponding to U.S. Patent No. 4,876,126) describes medical instruments and production thereof, in which, inter alia, a water-soluble copolymer (coating polymer) of maleic anhydride and vinyl methyl ether, or a derivative of such a copolymer, which may not be necessarily water-soluble, is bonded preferably covalently, but optionally also ionically or adsorptively, to a polymer substrate. The surfaces of the coating are said to show good sliding properties, that is to say have a low coefficient of friction, in the moistened (aqueous-moist) state. The copolymer, like the other coating polymers O.Z. 5238 mentioned in the publication, is said to contain a hydrophilic group and -OH, -CONH2, -COOH, -NH2, -COO~, -SO-3 and NR3 are expressly mentioned as the hydrophilic group. During covalent bonding, the copolymer is bonded covalently to the polymer substrate by means of reactive groups, such as isocyanate, amino, aldehyde and epoxide groups. When the substrate polymers originally contain no reactive groups, they are pretreated with compounds which contain such a group.
Polyisocyanates, polyamines, polyaldehydes and polyepoxides are mentioned as suitable compounds having reactive groups.
SummarY of the Invention It is an object of the invention to provide novel polymers which are suitable as coating compositions, and at the same time are bioactive and have a low-friction surface in the aqueous-moist state, the bioactivity and the low frictional resistance (or the good sliding properties) originating from the choice of certain functional groups, without further treatment being necessary.
Accordingly, the present invention provides a copolymer which is made of repeating units derived from monomers consisting essentially of:
(A) maleic anhydride (monomer A);
(B) at least one vinyl alkyl ether having an alkyl radical of 1 to 6 carbon atoms (monomer B);
(C) at least one vinyl monomer containing a carboxyl and/or carboxylate group (monomer C); and (D) at least one vinyl monomer containing a sulfuric o.z. 5238 acid, sulfate, sulfonic acid and/or sulfonate group (monomer D).
The polymer according to the invention contains acid groups (i.e., carboxyl and sulfuric or sulfonic groups) and/or anionic groups derived therefrom. Counterions for the anionic groups are preferably physiologically acceptable cations, such as alkali metal ions, in particular sodium ions, or ammonium ions, including quaternary ammonium ions. The molar ratio of the acid groups to the anionic groups may be varied, depending on the intended use of the polymer, by choice of corresponding monomers or can be modified subsequently by treatment with acids or bases. For example, as a rule no sulfuric acid or sulfonic acid groups should be present for medical uses, but this may be acceptable for uses in other technical fields.
The invention also relates to a process for the preparation of the polymer according to the invention, in which monomers A, B, C and D and where appropriate E, are subjected to free-radical polymerization.
The invention also relates to a process for coating substrates in which the copolymer is covalently bonded to the substrate.
The invention also relates to use of a polymer disclosed herein for production of a product for using the field of foodstuffs, tobacco, the water industry, bioengineering, hygiene provision, or medicine.
Finally, the invention relates to products (i.e.
articles) which are coated completely or partly with a polymer O.Z. 5238 disclosed herein and are suitable for use in the fields of foodstuffs and luxury foods, the water industry, bioengineering, hygiene provision and, in particular, medicine.
The polymers according to the invention show a remarkable combination of advantageous properties and therefore an outstanding physiological tolerability. They are readily compatible with blood and reduce the adhesion and multiplication of bacteria to a high degree, even over a relatively long time. This applies, inter alia, to the bacteria of the strains StaPhylococcus aureus, Sta~hylococcus e~idermis, Streptococcus pyo~enes, Klebsiella pneumoniae, Pseudomonas aeruqinosa and Esc~erichia coli. At the same time, the proliferation of cells, for example of umbilical cells, is usually also inhibited. The particular conditions under which a polymer is bacteria-repellent but cell proliferation-promoting are explained later. The surfaces of the polymers according to the invention are free from monomers and oligomers which are capable of migration and/or can be extracted. No undesirable side effects, for example by exogenous substances liberated or by bacteria which have been killed, are observed. At the same time, and last but not least, the novel polymers have a remarkably low frictional resistance in the aqueous-moist state.
~escri~tion of Preferred Embodiments 1. Monomer A
The usual industrial pure or highly pure maleic O.Z. 5238 anhydride as is commercially available in commercial quantities is used as monomer A.
Prior Art European Patent Publication 0 166 998 (corresponding to U.S. Patent No. 4,876,126) describes medical instruments and production thereof, in which, inter alia, a water-soluble copolymer (coating polymer) of maleic anhydride and vinyl methyl ether, or a derivative of such a copolymer, which may not be necessarily water-soluble, is bonded preferably covalently, but optionally also ionically or adsorptively, to a polymer substrate. The surfaces of the coating are said to show good sliding properties, that is to say have a low coefficient of friction, in the moistened (aqueous-moist) state. The copolymer, like the other coating polymers O.Z. 5238 mentioned in the publication, is said to contain a hydrophilic group and -OH, -CONH2, -COOH, -NH2, -COO~, -SO-3 and NR3 are expressly mentioned as the hydrophilic group. During covalent bonding, the copolymer is bonded covalently to the polymer substrate by means of reactive groups, such as isocyanate, amino, aldehyde and epoxide groups. When the substrate polymers originally contain no reactive groups, they are pretreated with compounds which contain such a group.
Polyisocyanates, polyamines, polyaldehydes and polyepoxides are mentioned as suitable compounds having reactive groups.
SummarY of the Invention It is an object of the invention to provide novel polymers which are suitable as coating compositions, and at the same time are bioactive and have a low-friction surface in the aqueous-moist state, the bioactivity and the low frictional resistance (or the good sliding properties) originating from the choice of certain functional groups, without further treatment being necessary.
Accordingly, the present invention provides a copolymer which is made of repeating units derived from monomers consisting essentially of:
(A) maleic anhydride (monomer A);
(B) at least one vinyl alkyl ether having an alkyl radical of 1 to 6 carbon atoms (monomer B);
(C) at least one vinyl monomer containing a carboxyl and/or carboxylate group (monomer C); and (D) at least one vinyl monomer containing a sulfuric o.z. 5238 acid, sulfate, sulfonic acid and/or sulfonate group (monomer D).
The polymer according to the invention contains acid groups (i.e., carboxyl and sulfuric or sulfonic groups) and/or anionic groups derived therefrom. Counterions for the anionic groups are preferably physiologically acceptable cations, such as alkali metal ions, in particular sodium ions, or ammonium ions, including quaternary ammonium ions. The molar ratio of the acid groups to the anionic groups may be varied, depending on the intended use of the polymer, by choice of corresponding monomers or can be modified subsequently by treatment with acids or bases. For example, as a rule no sulfuric acid or sulfonic acid groups should be present for medical uses, but this may be acceptable for uses in other technical fields.
The invention also relates to a process for the preparation of the polymer according to the invention, in which monomers A, B, C and D and where appropriate E, are subjected to free-radical polymerization.
The invention also relates to a process for coating substrates in which the copolymer is covalently bonded to the substrate.
The invention also relates to use of a polymer disclosed herein for production of a product for using the field of foodstuffs, tobacco, the water industry, bioengineering, hygiene provision, or medicine.
Finally, the invention relates to products (i.e.
articles) which are coated completely or partly with a polymer O.Z. 5238 disclosed herein and are suitable for use in the fields of foodstuffs and luxury foods, the water industry, bioengineering, hygiene provision and, in particular, medicine.
The polymers according to the invention show a remarkable combination of advantageous properties and therefore an outstanding physiological tolerability. They are readily compatible with blood and reduce the adhesion and multiplication of bacteria to a high degree, even over a relatively long time. This applies, inter alia, to the bacteria of the strains StaPhylococcus aureus, Sta~hylococcus e~idermis, Streptococcus pyo~enes, Klebsiella pneumoniae, Pseudomonas aeruqinosa and Esc~erichia coli. At the same time, the proliferation of cells, for example of umbilical cells, is usually also inhibited. The particular conditions under which a polymer is bacteria-repellent but cell proliferation-promoting are explained later. The surfaces of the polymers according to the invention are free from monomers and oligomers which are capable of migration and/or can be extracted. No undesirable side effects, for example by exogenous substances liberated or by bacteria which have been killed, are observed. At the same time, and last but not least, the novel polymers have a remarkably low frictional resistance in the aqueous-moist state.
~escri~tion of Preferred Embodiments 1. Monomer A
The usual industrial pure or highly pure maleic O.Z. 5238 anhydride as is commercially available in commercial quantities is used as monomer A.
2. Vinyl monomers B
The vinyl monomers B are vinyl alkyl ethers with alkyl radicals which have 1 to 6 carbon atoms, advantageously 1 to 4 carbon atoms. Vinyl ethyl ether and, in particular, vinyl methyl ether are preferred.
The vinyl monomers B are vinyl alkyl ethers with alkyl radicals which have 1 to 6 carbon atoms, advantageously 1 to 4 carbon atoms. Vinyl ethyl ether and, in particular, vinyl methyl ether are preferred.
3. Monomers C
The monomer~ C are preferably ethylenically unsaturated mono-or dicarboxylic acids and their salts.
Preferred monomers C correspond to the general formula:
(CnH2n_q_x)(COOR )x (I) in which n in each case independently is an integer from 2 to 6;
x in each case independently is 1 or 2, preferably 1;
g in each case independently is 0 or 2; and R1 in each case independently is -H, an alkali metal ion or an ammonium ion of the formula N(R )4 , in which R5 in each case independently is hydrogen or an organic radical, preferably a hydrocarbon radical having 1 to 20 carbon atoms.
When _ is 1, the monomer~ C are unsaturated monocarboxylic acids. Example~ of suitable monomers C which may be mentioned are: acrylic acid, methacrylic acid, 4-vinylsalicylic acid, itaconic acid, vinylacetic acid, cinnamic acid, 4-vinylbenzoic acid, 2-vinylbenzoic acid, sorbic acid, O.Z. 5238 caffeic acid, methylmaleic acid, crotonic acid, isocrotonic acid, fumaric acid, dimethlyfumaric acid, methylfumaric acid, dihydroxymaleic acid, allylacetic acid and the sodium salts and ammonium salts of these acids with the cation N(R5)4+.
Examples of this cation are ammonium, methylammonium, dimethylammonium, trimethylammonium, tetramethylammonium, dimethyl-l-n-octylammonium, dimethyl-l-n-octadecylammonium, dimethylbenzylammonium and dimethylanilinium.
Monomers C derived from benzene, of the general formula ( 6H6~b-c-d)[~cnH2n-l-q-x)(cOOR )x]bR c(OH)d (II) wherein Rl, n, ~ and _ are as defined above;
R3 in each case independently is Cl 4-alkyl, -NH2, -COOH, -SO3H, -OSO3H, -OPO(OH)2, -PO(OH)2, -OP(OH)2, -OPO(O-)OCH2-CH2 -N (CH3)3, -PO(O-)O-CH2-CH2 -N+ (CH3)3, -OP(O-)OCH2-CH2-N+(CH3)3 or a salt, in particular an alkali metal salt, of the - groups mentioned;
k iS 1, 2 or 3;
c is 0, 1, 2 or 3; and _ is 0, 1, 2 or 3;
with the provision that b + c + _ 5 6, advantageously 5 4, can also be contained in the polymer according to the invention.
4. Monomers D
The monomers D are ethylenically unsaturated organic mono- or disulfuric acids or mono- or disulfonic acids and their salts.
O.Z. 5238 Preferred monomers D containing sulfonic acid and/or sulfonate groups correspond to the general formula (CnH2n_q_x)(S03R )x (III) in which _, x, ~ and Rl have the meaning given for the formula I.
Suitable monomers D of the formula III containing sulfonic acid and/or sulfonate groups are, inter alia, sodium allylsulfonate, sodium methallylsulfonate, sodium vinylsulfonic acid, sodium vinylsulfonate, 4-styrenesulfonic acid, 2-styrenesulfonic acid, sodium 2-styrenesulfonate, sodium 4-styrenesulfonate, sodium vinyltoluenesulfonate, dimethyl-l-n-octylammonium 4-styrenesulfonate and dimethyl-l-n-octylammonium-2-styrenesulfonate.
Monomers containing sulfonic acid and/or sulfonate groups and derived from benzene, of the general formula (C6H6b-c-d)[(cnH2n-l-q-x)(so3Rl)x]bR3c(OH)d (IV) in which Rl, n, ~ and x and R3, b, c and d are as defined above, are also suitable as monomers D.
Other suitable monomers D contain sulfuric acid and/or sulfate groups. Of these, sodium allyl sulfate and sodium methallyl sulfate may be mentioned as examples.
A preferred group of monomers D containing sulfate groups are of the general formula:
O.Z. 5238 (H-l-R3- R4)n H- f - R3-R4 H
in which:
R1 is a hydrogen atom or a methyl radical, R2 is a divalent organic radical, preferably an aliphatic, cycloaliphatic or aromatic hydrocarbon radical having up to 10 carbon atoms, or a single bond, R3 is -O- or -NH-, R4 is hydrogen, the radical -S03-Na+ or the radical -So3-N(R5)4+, in which R5 has the meaning given in formula I, and n is 4 or 5;
with the proviso that at least one of the substituents R4 is a radical -S03-Na+ or -So3-N(R5)4+.
In preferred monomers D of the formula V, R1 is hydrogen, R2 is an alkylene radical having 1 to 4 carbon atoms, a phenylene radical or a single bond, R3 is -O- or -NH-, R4 is hydrogen or the radical -S03-Na+ and n is 4.
The monomers D of the formula V contain modified sugar residues which are preferably derived from pentoses, and in particular from arabinose. The sugar residues contain at o.z. 5238 least one of the radicals -O-S03-Na+ ("O-sulfate") or -NH-SO3-Na+ ("N-sulfate"), preferably adjacent to the radical R2.
They preferably contain 1 to 4 of these radicals. O-sulfate and N-sulfate radicals can be present simultaneously in a sugar residue, in which case the N-sulfate radical is then preferably positioned adjacent to the radical R2.
Alternatively, however, the sugar residue can also contain exclusively one type of these radicals, for example only O-sulfate radicals. Each of the species mentioned ~radicals containing only O-sulfate and N-sulfate-containing radicals) is suitable by itself or together with the other species as monomer D of the formula V. The ratio of the mixture is thus 0:100 to 100:0.
The preparation of monomers D of the formula V is described below 4.1 Monomers of formula V derived from pentitols The preparation of monomers of formula V is described by means of a special case starting from D-glucono-1,5-lactone 1 and resulting in a monomer of formula V which is derived from a pentose, namely D-arabinose. However, the skilled worker will be able to apply the process without difficulty to other suitable precursors.
In a first stage, the hydroxyl groups of the lactone 1 are protected by acetalization, for example with acetone, and, at the same time, the (cyclic) lactone is transesterified with methanol to give the (open-chain) methyl ester. An isomer mixture consisting of methyl 3,4j5,6-di-O-O. Z. 5238 isopropylidene-D-gluconate 2 and methyl 2,3j5,6-di-O-isopropylidene-D-gluconate 3 is obtained. This mixture is reduced in a second stage, for example with lithium aluminum hydride, whereby the carboxylic ester functionality becomes a carbinol functionality. Once again, a mixture of isomers is obtained, namely 3,4jS,6-di-O-isopropylidene-D-sorbitol 4 and 2,3;5,6-di-O-isopropylidene-D-sorbitol 5. In a third stage, this mixture of isomers is oxidized with an oxidizing agent such as sodium periodate with cleavage of the carbon chain to give a single product, the arabinose aldehyde 2,3;4,5-di-O-isopropylidenealdehydo-~-arabinose 6. In the subsequent fourth stage, a vinyl functionality is introduced, for example by a Grignard reaction with 4-vinylphenylmagnesium chloride.
A partly protected 4-vinylphenylpentanepentaol, 2,3;4,5-di-O-isopropylidene-l-(4-vinylphenyl)-D-gluco(D-manno)-pentitol 7 is obtained and is referred to as arasty for brevity hereinafter.
This sequence of stages 1 to 4 is illustrated by the following reaction scheme.
O. Z. 5238 CH20H CC~X~H3 ~ COOCH3 H ~ CH30H;
--O~ --O~
_o \ --~~\
2 3 ~
- OH ~ - OH ~ ~d - OH - O CHO T
~ 4-c~o- CHOH
o ~ O N~O4 ~ ~ ~y~
- oX --OX - oX - ~X
- O
__ _ _ The sequence of reactions in stages 1 to 3 (that is to say up to compound 6) has been described by H. Regeling et al., Recl. Trav. Chim. Pays-Bas 1987, (106) 461 and D.Y.
Jackson, Synth. Commun. 1988 (18) 337. Stage 4 (to compound 7) was published for the first time by G. Wulff et al., Macromol. Chem. Phys. 1996 (197) 1285.
To prepare a compound corresponding to arasty 7 with an amino group in position 1 it is possible, in a first stage, to oxidize arasty to the corresponding ketone, 2,3j4,5-di-O-isopropylidene-D-arabino 4-vinylphenyl ketone 8. This is converted by reduction in a second stage to 1-amino-1-deoxy-2,3;4,5-di-O-isopropylidene-1-(4-vinylphenyl)-D-gluco(D-manno)-pentitol 9. This sequence of reactions is illustrated by the following formula diagram:
o.z. 5238 0 ~ DMSO/(cOcl)2 O ~ NaCNBH2 O
--O --O --O
--O~ '--O / --O
_0/\ _o~ _OX
_ 8 9 In the first stage, arasty 7 can be oxidized for example with oxalyl chloride and dimethyl sulfoxide at a temperature <-50~C in an inert solvent. The reductive amination in the second stage is advantageously achieved with sodium cyanoborohydride as reducing agent in the presence of ammonium acetate in a solvent with exclusion of water at room temperature.
Heparin contains unprotected hydroxyl groups and is O-sulfated and N-sulfated. Compounds 7 and 9 are therefore deprotected (deacetalized) in a first stage and 0- and/or N-sulfated in a second stage so that the polymer prepared from them is as far as possible analogous to heparin. The deprotection takes place in acidic medium in which ketals are unstable. The protected compounds are heated, for example, with dilute mineral acid or an acidic ion exchanger to obtain from 7 1-(4-vinylphenyl)-D-gluco(D-manno)-pentitol 10 and from 9 l-amino-l-deoxy-l-(4-vinylphenyl)-D-gluco(D-manno)-pentit o. z. 5238 11. The deprotection and the subsequent sulfation are depicted in the following formula diagram:
CHOH ~mh~lit~ ~120 CHOH ~a~on CHOR
H+form HO- RO --OH -OR
-OH -OR
_O X OH -OR
7 1o 12 R~HorSO3-Na+
1 ~2 \-~ \ ~
o ~ a.1NH~CHNH2 ~a~on CHNHR
HO- RO--OH -OR
_O X OH -OR
-OH -OR
R=HorSO3-Na+
The two compounds 10 and 11 are sulfated, expediently using a sulfur trioxide/pyridine complex. Because of the preceding deacetalization, the sulfation does not result in a single product with one or more sulfate groups in defined positions. However, the primary hydroxyl groups and the amino groups ought to be preferentially sulfated. The degree of sulfation can be controlled by choice of a suitable * Trade-mark o.z. 5238 molar ratio of sulfur trioxide to hydroxyl and amino groups.
It is advantageous for more than one sulfate group to be introduced on average per molecule, because heparin contains about 2.7 sulfate groups per disaccharide unit (equivalent to 1.35 sulfate groups per molecule of monomer I). Sulfation of the deprotected amine compound 11 results in both O-sulfate and N-sulfate groups in the molecule, which is desired in the light of the intended analogy to heparin.
The sulfation is advantageously carried out at room temperature in order to avoid premature polymerization. It is nevertheless possible, by a relatively long reaction time, for example up to 100 hours, for the reaction to be continued until all the OH and NH2 groups have reacted completely. It is possible to use as solvent for example excess pyridine or an ether such as tetrahydrofuran. Since the sulfate groups in the reaction products are unstable to acid, it is advisable to add a dehydrating agent, for example molecular sieves, to the precursor solution before adding the sulfur trioxide/pyridine complex. For the same reason it is advisable, after completion of the reaction, to hydrolyze the reaction mixture first by adding water and shortly thereafter a base (which keeps the pH in the alkaline range). An example of a suitable base is a saturated barium hydroxide solution, which also precipitates sulfate ions. Excess barium ions can be precipitated, for example, by passing in carbon dioxide, where appropriate after cautious concentration to remove solvent.
The barium carbonate is filtered off and the filtrate is O.Z. 5238 passed through an ion exchange column in the Na+ form, or treated with the ion exchanger in another way, in order to replace the barium ions by sodium ions. The products, O-sulfated l-hydroxy-l-deoxy-l-(4-vinylphenyl)-D-gluco(D-manno)-pentitol 12 and N- and O-sulfated l-amino(4-vinylphenyl)-D-gluco(D-manno)-pentitol 13 can be isolated, in each case in the form of the sodium salt, as solid powders by freeze drying the solution which has been concentrated further.
4.2 Monomers of formula V derlved from hexitols The preparation of these monomers is described by means of another special case which starts once again from D-glucono-1,5-lactone 1 and results in two monomers which are formally derived from a hexose, namely D-glucose. However, the skilled worker will be able without difficulty to apply the process to other suitable precursors and prepare other monomers according to the invention.
D-Glucono-1,5-lactone 1 is first converted in a one-pot reaction with a secondary amine and acetone in acidic medium into a mixture of the regioisomers 3,4;5,6-di-O-isopropylidene-D-gluconic acid diethylamide 14 and 2,3j5,6-di-O-isopropylidene-D-gluconic acid diethylamide 15. A mixture of the isomers 3,4;5,6-di-O-isopropylidene-1-(4-vinylphenyl)-keto-D-glucose 16 and 2,3;5,6-di-O-isopropylidene-1-(4-vinylphenyl)-keto-D-glucose 17 is obtainable from this mixture by a Grignard reaction with phenylmagnesium chloride.
The mixture of isomers 16, 17 is hydrogenated ~or reduced), for example with sodium borohydride or lithium o.z. 5238 aluminum hydride, resulting in two pairs of regioisomeric diastereomers 3,4;5,6-di-0-isopropylidene-1-(4-vinylphenyl)-D-glycero-D-gulo(D-ido)-hexitol and 2,3;5,6-di-O-isopropylidene-1-(4-vinylphenyl)-D-glycero-D-gulo(D-ido)-hexitol 20 (not depicted in the following formula diagram). These can be deprotected in acidic medium, resulting in 1-(4-vinylphenyl)-D-glycero-D-gulo(D-ido)-hexitol 21. Sulfation, for example with the sulfur trioxide/pyridine complex as described thereof, results in the sulfation product 22, which is a monomer of formula V.
Alternatively, the mixture of isomers 16, 17 can be reductively aminated, for example with sodium cyanoborohydride and an ammonium salt. This results in two pairs of regioisomeric diastereomers 1-amino-1-deoxy-3,4;5,6-di-O-isopropylidene-1-(4-vinylphenyl)-D-glycero-D-gulo(D-ido)-hexitol and 1-amino-1-deoxy-2,3;5,6-di-O-isopropylidene-1-(4-vinylphenyl)-D-glycero-D-gulo(D-ido)-hexitol 23 (not depicted in the following formula diagram). These can in turn be deprotected in acidic medium, resulting in 1-amino-1-deoxy-1-(4-vinylphenyl)-D-glycero-D-gulo(D-ido)-hexitol 24. This is sulfated as described to give the sulfation product 25, which is likewise a monomer of formula V.
It is possible in both variants to reverse the sequence of hydrogenation or reductive amination and deprotection.
The described reaction sequence is depicted by the following formula diagram, intermediates 20 and 23 not being o.z. 5238 depicted:
~OH
~0 ~=0 HO OH
1. HNEt 2 2. Acetone / H
O~C,N~t 2 O~C,NEt2 --OH
O~ + O
--O --OH
- ~X - ~X
--O --O
1. CH3CH 2MgBr 2. ~MgCI
3. H20/H
o. z . 5238 C=O =O
-OH -O
O-- ~< ' O
-O -OH
_oX _oX
1~ 1 17 1. N~B~ 1 1. NH~OAclN~H3CN
2. ~-120 ~ ~ . ~-l~
-OH -OH
HC~- HO--OH -OH
-OH -OH
-OH -OH
S031P~l so31pyl O.Z. 5238 CHOR CHNHR
--OR --OR
RO-- RO----OR --OR
--OR --OR
--OR --OR
4.3 Monomers with acetalized or aminalized carbonyl functionality Preferred monomers of this type correspond to formula V:
( H--C--R3--R4)n (V) H
in which R1, R2, R3, R4 and n have the meanings stated above for formula V, including the preferred meanings; with the proviso that (1) at least once, advantageously once or twice, per molecule, substituents H and -R3-R4 on the same carbon atom o.z. 5238 form with this carbon atom a carbonyl functionality C=O which has undergone intramolecular acetalization or aminalization by a hydroxyl or amino functionality in position 3 relative to the carbonyl functionality to form a tetrahydrofuran or pyrrolidine ring or by a hydroxyl or amino functionality in position 4 relative to the carbonyl functionality to form a pyran or pentamethyleneimine ring, and that (2) at least one of the substituents R4 is a radical SO ~Na+
An acetalized or aminalized monomer of formula V can be prepared, for example, by first proceeding as described under 4.2, but preparing from the mixture of isomers 16, 17, by deprotection in acidic medium, a single product, namely 1-(4-vinylphenyl)-keto-D-glucose 18. This is converted in its acetal form by sulfation, once again for example with sulfur trioxide/pyridine, into the sulfated compound 19, which is a monomer of formula V. The sequence of stages is depicted by the following formula diagram O.Z. 5238 C -O C O IR-120 < o ~~ ~
~ - OH OR
O ~ O HO -_ O - OH - OH
--~ / --~~ ~' --OH
_ O~ O'~~ - OH 19 6 17 18 R- H or SO3Na Other monomers of formula V of the invention can be prepared starting from monomers which are initially still protected by intermolecular acetalization (with acetone) and are free of sulfate groups. The preparation of an unprotected monomer which is free of sulfate groups and is derived from a ketohexose will be described taking the example of 1-(4-vinylphenyl)-D-manno(D-gluco)-hexulo-2,6-pyranose 27. This starts from the acetone-protected 2,3;4,5-di-0-isopropylidene-1-(4-vinylphenyl)-D-manno(D-gluco)-hexulo-2,6-pyranose 26, whose preparation has been described by G. Wulff, J. Schmidt, T.P. Venhoff in Macrom. Chem. Phys., 197, 1285 (1996). An example for the preparation of a monomer which is free of sulfate groups and is derived from an aldohexose is the synthesis of 6-(4-vinylphenyl)-D-glycerol(L-glycero)-~-D-galactopyranose 30. The starting material in this case is 1,2;3,4-di-0-isopropylidene-6-(4-vinylphenyl)-D-glycero(L-glycero)-~-D-galactopyranose 29, whose preparation has o.z. 523823443-649 likewise been described by G. Wulff, J. Schmidt, T.P. Venhoff loc. cit. Deprotection of the hydroxyl groups takes place in both cases using an acidic ionic exchanger in an inert solvent, for example an alcohol, at moderately elevated temperature, such as 50 to 100~C, expediently in an inert gas atmosphere and in the presence of an oxidation inhibitor.
It is possible to prepare by sulfation of monomers 27 and 30 which are free of sulfate groups (R4 = H in each case) their completely or partly sulfated (R = SO3~Na+) derivatives. Once again a sulfur trioxide/pyridine complex, for example, is used, expediently at room temperature in order to avoid premature polymerization. The reaction is nevertheless complete after a relatively long time. The degree of sulfation can be determined by choice of a suitable molar ratio of sulfur trioxide to hydroxyl groups.
r O ~ IR - 120 ~ H~ SO3~ ~ ~ oO~OR
OH ~ ~ OR
R-H ~ SO3Na Preparation of monomers IV 28 and 31 is described by the following formula diagram:
o.Z. 5238 ~0 1R-I2~ ~ S
O ~ ~ OH ~ OR
29 30 R-H ~ SO3Na 5. Certain combination~ of monomers C and D
Instead of two monomers C and D having the formulae II and III, the polymer according to the invention can also comprise only one monomer (C+D) which contains the various characteristic groups of monomers C and D in the same molecule. It is also possible to employ two or more monomers C instead of only one monomer C, and two or more monomers D
instead of only one monomer D. It is thus possible to use a mixture of acrylic acid and sodium acrylate instead of acrylic acid by itself, and a mixture of sodium 4-styrenesulfonate and 4-styrene-sulfuric acid instead of sodium 4-styrenesulfonate.
A combination of monomer~ C and D which contains both of carboxyl and/or carboxylate groups and sulfonic acid and/or sulfonate groups has proven suitable for the polymers according to the invention. From the standpoint of compatibility, there are three possible two-component combinations of the groups mentioned, that is to say carboxyl and sulfonic acid groups, carboxyl and sulfonate groups and O.Z. 5238 carboxylate and sulfonate groups, and furthermore two three-component combinations, that is to say carboxyl, carboxylate and sulfonate groups and carboxyl, sulfonic acid and sulfonate groups. All these combinations characterize usable representatives of the polymers according to the invention.
The polymers can of course also comprise monomers which are formed by subsequent modification of functional groups after the polymerization. Thus, for example, the acrylamide unit can subsequently be converted into the acrylic acid unit by hydrolysis in an acid medium. Furthermore, carboxyl and sulfonic acid groups can be converted by neutralization (for example in phosphate buffers) and carboxylic ester and sulfonic acid ester groups can be converted by hydrolysis into carboxylate and sulfonate groups respectively.
In the combination of monomers C and D mentioned, the molar ratio of carboxyl and/or carboxylate groups to sulfonic acid and/or sulfonate groups can vary within wide limits. However, it is preferred in the range from 0.1 to 10.
At such a ratio, the polymers show pronounced bacteria-repellent properties. Particularly pronounced cellproliferation-inhibiting properties are additionally achieved if the ratio mentioned is 0.2 to 3, more preferably 0.4 to 3, and in particular 0.4 to 2. The coated surfaces remarkably show bacteria-repellent but cell proliferation-promoting properties if the molar ratio is 2 to 10, preferably 3 to 10, and in particular 3 to 5. A polymer is cell proliferation-promoting in the context of the invention if the adhesion and o.z. 5238 multiplication of mammalian cells is improved or at any rate less severely impaired than the adhesion and multiplication of bacteria.
The monomer~ C are preferably ethylenically unsaturated mono-or dicarboxylic acids and their salts.
Preferred monomers C correspond to the general formula:
(CnH2n_q_x)(COOR )x (I) in which n in each case independently is an integer from 2 to 6;
x in each case independently is 1 or 2, preferably 1;
g in each case independently is 0 or 2; and R1 in each case independently is -H, an alkali metal ion or an ammonium ion of the formula N(R )4 , in which R5 in each case independently is hydrogen or an organic radical, preferably a hydrocarbon radical having 1 to 20 carbon atoms.
When _ is 1, the monomer~ C are unsaturated monocarboxylic acids. Example~ of suitable monomers C which may be mentioned are: acrylic acid, methacrylic acid, 4-vinylsalicylic acid, itaconic acid, vinylacetic acid, cinnamic acid, 4-vinylbenzoic acid, 2-vinylbenzoic acid, sorbic acid, O.Z. 5238 caffeic acid, methylmaleic acid, crotonic acid, isocrotonic acid, fumaric acid, dimethlyfumaric acid, methylfumaric acid, dihydroxymaleic acid, allylacetic acid and the sodium salts and ammonium salts of these acids with the cation N(R5)4+.
Examples of this cation are ammonium, methylammonium, dimethylammonium, trimethylammonium, tetramethylammonium, dimethyl-l-n-octylammonium, dimethyl-l-n-octadecylammonium, dimethylbenzylammonium and dimethylanilinium.
Monomers C derived from benzene, of the general formula ( 6H6~b-c-d)[~cnH2n-l-q-x)(cOOR )x]bR c(OH)d (II) wherein Rl, n, ~ and _ are as defined above;
R3 in each case independently is Cl 4-alkyl, -NH2, -COOH, -SO3H, -OSO3H, -OPO(OH)2, -PO(OH)2, -OP(OH)2, -OPO(O-)OCH2-CH2 -N (CH3)3, -PO(O-)O-CH2-CH2 -N+ (CH3)3, -OP(O-)OCH2-CH2-N+(CH3)3 or a salt, in particular an alkali metal salt, of the - groups mentioned;
k iS 1, 2 or 3;
c is 0, 1, 2 or 3; and _ is 0, 1, 2 or 3;
with the provision that b + c + _ 5 6, advantageously 5 4, can also be contained in the polymer according to the invention.
4. Monomers D
The monomers D are ethylenically unsaturated organic mono- or disulfuric acids or mono- or disulfonic acids and their salts.
O.Z. 5238 Preferred monomers D containing sulfonic acid and/or sulfonate groups correspond to the general formula (CnH2n_q_x)(S03R )x (III) in which _, x, ~ and Rl have the meaning given for the formula I.
Suitable monomers D of the formula III containing sulfonic acid and/or sulfonate groups are, inter alia, sodium allylsulfonate, sodium methallylsulfonate, sodium vinylsulfonic acid, sodium vinylsulfonate, 4-styrenesulfonic acid, 2-styrenesulfonic acid, sodium 2-styrenesulfonate, sodium 4-styrenesulfonate, sodium vinyltoluenesulfonate, dimethyl-l-n-octylammonium 4-styrenesulfonate and dimethyl-l-n-octylammonium-2-styrenesulfonate.
Monomers containing sulfonic acid and/or sulfonate groups and derived from benzene, of the general formula (C6H6b-c-d)[(cnH2n-l-q-x)(so3Rl)x]bR3c(OH)d (IV) in which Rl, n, ~ and x and R3, b, c and d are as defined above, are also suitable as monomers D.
Other suitable monomers D contain sulfuric acid and/or sulfate groups. Of these, sodium allyl sulfate and sodium methallyl sulfate may be mentioned as examples.
A preferred group of monomers D containing sulfate groups are of the general formula:
O.Z. 5238 (H-l-R3- R4)n H- f - R3-R4 H
in which:
R1 is a hydrogen atom or a methyl radical, R2 is a divalent organic radical, preferably an aliphatic, cycloaliphatic or aromatic hydrocarbon radical having up to 10 carbon atoms, or a single bond, R3 is -O- or -NH-, R4 is hydrogen, the radical -S03-Na+ or the radical -So3-N(R5)4+, in which R5 has the meaning given in formula I, and n is 4 or 5;
with the proviso that at least one of the substituents R4 is a radical -S03-Na+ or -So3-N(R5)4+.
In preferred monomers D of the formula V, R1 is hydrogen, R2 is an alkylene radical having 1 to 4 carbon atoms, a phenylene radical or a single bond, R3 is -O- or -NH-, R4 is hydrogen or the radical -S03-Na+ and n is 4.
The monomers D of the formula V contain modified sugar residues which are preferably derived from pentoses, and in particular from arabinose. The sugar residues contain at o.z. 5238 least one of the radicals -O-S03-Na+ ("O-sulfate") or -NH-SO3-Na+ ("N-sulfate"), preferably adjacent to the radical R2.
They preferably contain 1 to 4 of these radicals. O-sulfate and N-sulfate radicals can be present simultaneously in a sugar residue, in which case the N-sulfate radical is then preferably positioned adjacent to the radical R2.
Alternatively, however, the sugar residue can also contain exclusively one type of these radicals, for example only O-sulfate radicals. Each of the species mentioned ~radicals containing only O-sulfate and N-sulfate-containing radicals) is suitable by itself or together with the other species as monomer D of the formula V. The ratio of the mixture is thus 0:100 to 100:0.
The preparation of monomers D of the formula V is described below 4.1 Monomers of formula V derived from pentitols The preparation of monomers of formula V is described by means of a special case starting from D-glucono-1,5-lactone 1 and resulting in a monomer of formula V which is derived from a pentose, namely D-arabinose. However, the skilled worker will be able to apply the process without difficulty to other suitable precursors.
In a first stage, the hydroxyl groups of the lactone 1 are protected by acetalization, for example with acetone, and, at the same time, the (cyclic) lactone is transesterified with methanol to give the (open-chain) methyl ester. An isomer mixture consisting of methyl 3,4j5,6-di-O-O. Z. 5238 isopropylidene-D-gluconate 2 and methyl 2,3j5,6-di-O-isopropylidene-D-gluconate 3 is obtained. This mixture is reduced in a second stage, for example with lithium aluminum hydride, whereby the carboxylic ester functionality becomes a carbinol functionality. Once again, a mixture of isomers is obtained, namely 3,4jS,6-di-O-isopropylidene-D-sorbitol 4 and 2,3;5,6-di-O-isopropylidene-D-sorbitol 5. In a third stage, this mixture of isomers is oxidized with an oxidizing agent such as sodium periodate with cleavage of the carbon chain to give a single product, the arabinose aldehyde 2,3;4,5-di-O-isopropylidenealdehydo-~-arabinose 6. In the subsequent fourth stage, a vinyl functionality is introduced, for example by a Grignard reaction with 4-vinylphenylmagnesium chloride.
A partly protected 4-vinylphenylpentanepentaol, 2,3;4,5-di-O-isopropylidene-l-(4-vinylphenyl)-D-gluco(D-manno)-pentitol 7 is obtained and is referred to as arasty for brevity hereinafter.
This sequence of stages 1 to 4 is illustrated by the following reaction scheme.
O. Z. 5238 CH20H CC~X~H3 ~ COOCH3 H ~ CH30H;
--O~ --O~
_o \ --~~\
2 3 ~
- OH ~ - OH ~ ~d - OH - O CHO T
~ 4-c~o- CHOH
o ~ O N~O4 ~ ~ ~y~
- oX --OX - oX - ~X
- O
__ _ _ The sequence of reactions in stages 1 to 3 (that is to say up to compound 6) has been described by H. Regeling et al., Recl. Trav. Chim. Pays-Bas 1987, (106) 461 and D.Y.
Jackson, Synth. Commun. 1988 (18) 337. Stage 4 (to compound 7) was published for the first time by G. Wulff et al., Macromol. Chem. Phys. 1996 (197) 1285.
To prepare a compound corresponding to arasty 7 with an amino group in position 1 it is possible, in a first stage, to oxidize arasty to the corresponding ketone, 2,3j4,5-di-O-isopropylidene-D-arabino 4-vinylphenyl ketone 8. This is converted by reduction in a second stage to 1-amino-1-deoxy-2,3;4,5-di-O-isopropylidene-1-(4-vinylphenyl)-D-gluco(D-manno)-pentitol 9. This sequence of reactions is illustrated by the following formula diagram:
o.z. 5238 0 ~ DMSO/(cOcl)2 O ~ NaCNBH2 O
--O --O --O
--O~ '--O / --O
_0/\ _o~ _OX
_ 8 9 In the first stage, arasty 7 can be oxidized for example with oxalyl chloride and dimethyl sulfoxide at a temperature <-50~C in an inert solvent. The reductive amination in the second stage is advantageously achieved with sodium cyanoborohydride as reducing agent in the presence of ammonium acetate in a solvent with exclusion of water at room temperature.
Heparin contains unprotected hydroxyl groups and is O-sulfated and N-sulfated. Compounds 7 and 9 are therefore deprotected (deacetalized) in a first stage and 0- and/or N-sulfated in a second stage so that the polymer prepared from them is as far as possible analogous to heparin. The deprotection takes place in acidic medium in which ketals are unstable. The protected compounds are heated, for example, with dilute mineral acid or an acidic ion exchanger to obtain from 7 1-(4-vinylphenyl)-D-gluco(D-manno)-pentitol 10 and from 9 l-amino-l-deoxy-l-(4-vinylphenyl)-D-gluco(D-manno)-pentit o. z. 5238 11. The deprotection and the subsequent sulfation are depicted in the following formula diagram:
CHOH ~mh~lit~ ~120 CHOH ~a~on CHOR
H+form HO- RO --OH -OR
-OH -OR
_O X OH -OR
7 1o 12 R~HorSO3-Na+
1 ~2 \-~ \ ~
o ~ a.1NH~CHNH2 ~a~on CHNHR
HO- RO--OH -OR
_O X OH -OR
-OH -OR
R=HorSO3-Na+
The two compounds 10 and 11 are sulfated, expediently using a sulfur trioxide/pyridine complex. Because of the preceding deacetalization, the sulfation does not result in a single product with one or more sulfate groups in defined positions. However, the primary hydroxyl groups and the amino groups ought to be preferentially sulfated. The degree of sulfation can be controlled by choice of a suitable * Trade-mark o.z. 5238 molar ratio of sulfur trioxide to hydroxyl and amino groups.
It is advantageous for more than one sulfate group to be introduced on average per molecule, because heparin contains about 2.7 sulfate groups per disaccharide unit (equivalent to 1.35 sulfate groups per molecule of monomer I). Sulfation of the deprotected amine compound 11 results in both O-sulfate and N-sulfate groups in the molecule, which is desired in the light of the intended analogy to heparin.
The sulfation is advantageously carried out at room temperature in order to avoid premature polymerization. It is nevertheless possible, by a relatively long reaction time, for example up to 100 hours, for the reaction to be continued until all the OH and NH2 groups have reacted completely. It is possible to use as solvent for example excess pyridine or an ether such as tetrahydrofuran. Since the sulfate groups in the reaction products are unstable to acid, it is advisable to add a dehydrating agent, for example molecular sieves, to the precursor solution before adding the sulfur trioxide/pyridine complex. For the same reason it is advisable, after completion of the reaction, to hydrolyze the reaction mixture first by adding water and shortly thereafter a base (which keeps the pH in the alkaline range). An example of a suitable base is a saturated barium hydroxide solution, which also precipitates sulfate ions. Excess barium ions can be precipitated, for example, by passing in carbon dioxide, where appropriate after cautious concentration to remove solvent.
The barium carbonate is filtered off and the filtrate is O.Z. 5238 passed through an ion exchange column in the Na+ form, or treated with the ion exchanger in another way, in order to replace the barium ions by sodium ions. The products, O-sulfated l-hydroxy-l-deoxy-l-(4-vinylphenyl)-D-gluco(D-manno)-pentitol 12 and N- and O-sulfated l-amino(4-vinylphenyl)-D-gluco(D-manno)-pentitol 13 can be isolated, in each case in the form of the sodium salt, as solid powders by freeze drying the solution which has been concentrated further.
4.2 Monomers of formula V derlved from hexitols The preparation of these monomers is described by means of another special case which starts once again from D-glucono-1,5-lactone 1 and results in two monomers which are formally derived from a hexose, namely D-glucose. However, the skilled worker will be able without difficulty to apply the process to other suitable precursors and prepare other monomers according to the invention.
D-Glucono-1,5-lactone 1 is first converted in a one-pot reaction with a secondary amine and acetone in acidic medium into a mixture of the regioisomers 3,4;5,6-di-O-isopropylidene-D-gluconic acid diethylamide 14 and 2,3j5,6-di-O-isopropylidene-D-gluconic acid diethylamide 15. A mixture of the isomers 3,4;5,6-di-O-isopropylidene-1-(4-vinylphenyl)-keto-D-glucose 16 and 2,3;5,6-di-O-isopropylidene-1-(4-vinylphenyl)-keto-D-glucose 17 is obtainable from this mixture by a Grignard reaction with phenylmagnesium chloride.
The mixture of isomers 16, 17 is hydrogenated ~or reduced), for example with sodium borohydride or lithium o.z. 5238 aluminum hydride, resulting in two pairs of regioisomeric diastereomers 3,4;5,6-di-0-isopropylidene-1-(4-vinylphenyl)-D-glycero-D-gulo(D-ido)-hexitol and 2,3;5,6-di-O-isopropylidene-1-(4-vinylphenyl)-D-glycero-D-gulo(D-ido)-hexitol 20 (not depicted in the following formula diagram). These can be deprotected in acidic medium, resulting in 1-(4-vinylphenyl)-D-glycero-D-gulo(D-ido)-hexitol 21. Sulfation, for example with the sulfur trioxide/pyridine complex as described thereof, results in the sulfation product 22, which is a monomer of formula V.
Alternatively, the mixture of isomers 16, 17 can be reductively aminated, for example with sodium cyanoborohydride and an ammonium salt. This results in two pairs of regioisomeric diastereomers 1-amino-1-deoxy-3,4;5,6-di-O-isopropylidene-1-(4-vinylphenyl)-D-glycero-D-gulo(D-ido)-hexitol and 1-amino-1-deoxy-2,3;5,6-di-O-isopropylidene-1-(4-vinylphenyl)-D-glycero-D-gulo(D-ido)-hexitol 23 (not depicted in the following formula diagram). These can in turn be deprotected in acidic medium, resulting in 1-amino-1-deoxy-1-(4-vinylphenyl)-D-glycero-D-gulo(D-ido)-hexitol 24. This is sulfated as described to give the sulfation product 25, which is likewise a monomer of formula V.
It is possible in both variants to reverse the sequence of hydrogenation or reductive amination and deprotection.
The described reaction sequence is depicted by the following formula diagram, intermediates 20 and 23 not being o.z. 5238 depicted:
~OH
~0 ~=0 HO OH
1. HNEt 2 2. Acetone / H
O~C,N~t 2 O~C,NEt2 --OH
O~ + O
--O --OH
- ~X - ~X
--O --O
1. CH3CH 2MgBr 2. ~MgCI
3. H20/H
o. z . 5238 C=O =O
-OH -O
O-- ~< ' O
-O -OH
_oX _oX
1~ 1 17 1. N~B~ 1 1. NH~OAclN~H3CN
2. ~-120 ~ ~ . ~-l~
-OH -OH
HC~- HO--OH -OH
-OH -OH
-OH -OH
S031P~l so31pyl O.Z. 5238 CHOR CHNHR
--OR --OR
RO-- RO----OR --OR
--OR --OR
--OR --OR
4.3 Monomers with acetalized or aminalized carbonyl functionality Preferred monomers of this type correspond to formula V:
( H--C--R3--R4)n (V) H
in which R1, R2, R3, R4 and n have the meanings stated above for formula V, including the preferred meanings; with the proviso that (1) at least once, advantageously once or twice, per molecule, substituents H and -R3-R4 on the same carbon atom o.z. 5238 form with this carbon atom a carbonyl functionality C=O which has undergone intramolecular acetalization or aminalization by a hydroxyl or amino functionality in position 3 relative to the carbonyl functionality to form a tetrahydrofuran or pyrrolidine ring or by a hydroxyl or amino functionality in position 4 relative to the carbonyl functionality to form a pyran or pentamethyleneimine ring, and that (2) at least one of the substituents R4 is a radical SO ~Na+
An acetalized or aminalized monomer of formula V can be prepared, for example, by first proceeding as described under 4.2, but preparing from the mixture of isomers 16, 17, by deprotection in acidic medium, a single product, namely 1-(4-vinylphenyl)-keto-D-glucose 18. This is converted in its acetal form by sulfation, once again for example with sulfur trioxide/pyridine, into the sulfated compound 19, which is a monomer of formula V. The sequence of stages is depicted by the following formula diagram O.Z. 5238 C -O C O IR-120 < o ~~ ~
~ - OH OR
O ~ O HO -_ O - OH - OH
--~ / --~~ ~' --OH
_ O~ O'~~ - OH 19 6 17 18 R- H or SO3Na Other monomers of formula V of the invention can be prepared starting from monomers which are initially still protected by intermolecular acetalization (with acetone) and are free of sulfate groups. The preparation of an unprotected monomer which is free of sulfate groups and is derived from a ketohexose will be described taking the example of 1-(4-vinylphenyl)-D-manno(D-gluco)-hexulo-2,6-pyranose 27. This starts from the acetone-protected 2,3;4,5-di-0-isopropylidene-1-(4-vinylphenyl)-D-manno(D-gluco)-hexulo-2,6-pyranose 26, whose preparation has been described by G. Wulff, J. Schmidt, T.P. Venhoff in Macrom. Chem. Phys., 197, 1285 (1996). An example for the preparation of a monomer which is free of sulfate groups and is derived from an aldohexose is the synthesis of 6-(4-vinylphenyl)-D-glycerol(L-glycero)-~-D-galactopyranose 30. The starting material in this case is 1,2;3,4-di-0-isopropylidene-6-(4-vinylphenyl)-D-glycero(L-glycero)-~-D-galactopyranose 29, whose preparation has o.z. 523823443-649 likewise been described by G. Wulff, J. Schmidt, T.P. Venhoff loc. cit. Deprotection of the hydroxyl groups takes place in both cases using an acidic ionic exchanger in an inert solvent, for example an alcohol, at moderately elevated temperature, such as 50 to 100~C, expediently in an inert gas atmosphere and in the presence of an oxidation inhibitor.
It is possible to prepare by sulfation of monomers 27 and 30 which are free of sulfate groups (R4 = H in each case) their completely or partly sulfated (R = SO3~Na+) derivatives. Once again a sulfur trioxide/pyridine complex, for example, is used, expediently at room temperature in order to avoid premature polymerization. The reaction is nevertheless complete after a relatively long time. The degree of sulfation can be determined by choice of a suitable molar ratio of sulfur trioxide to hydroxyl groups.
r O ~ IR - 120 ~ H~ SO3~ ~ ~ oO~OR
OH ~ ~ OR
R-H ~ SO3Na Preparation of monomers IV 28 and 31 is described by the following formula diagram:
o.Z. 5238 ~0 1R-I2~ ~ S
O ~ ~ OH ~ OR
29 30 R-H ~ SO3Na 5. Certain combination~ of monomers C and D
Instead of two monomers C and D having the formulae II and III, the polymer according to the invention can also comprise only one monomer (C+D) which contains the various characteristic groups of monomers C and D in the same molecule. It is also possible to employ two or more monomers C instead of only one monomer C, and two or more monomers D
instead of only one monomer D. It is thus possible to use a mixture of acrylic acid and sodium acrylate instead of acrylic acid by itself, and a mixture of sodium 4-styrenesulfonate and 4-styrene-sulfuric acid instead of sodium 4-styrenesulfonate.
A combination of monomer~ C and D which contains both of carboxyl and/or carboxylate groups and sulfonic acid and/or sulfonate groups has proven suitable for the polymers according to the invention. From the standpoint of compatibility, there are three possible two-component combinations of the groups mentioned, that is to say carboxyl and sulfonic acid groups, carboxyl and sulfonate groups and O.Z. 5238 carboxylate and sulfonate groups, and furthermore two three-component combinations, that is to say carboxyl, carboxylate and sulfonate groups and carboxyl, sulfonic acid and sulfonate groups. All these combinations characterize usable representatives of the polymers according to the invention.
The polymers can of course also comprise monomers which are formed by subsequent modification of functional groups after the polymerization. Thus, for example, the acrylamide unit can subsequently be converted into the acrylic acid unit by hydrolysis in an acid medium. Furthermore, carboxyl and sulfonic acid groups can be converted by neutralization (for example in phosphate buffers) and carboxylic ester and sulfonic acid ester groups can be converted by hydrolysis into carboxylate and sulfonate groups respectively.
In the combination of monomers C and D mentioned, the molar ratio of carboxyl and/or carboxylate groups to sulfonic acid and/or sulfonate groups can vary within wide limits. However, it is preferred in the range from 0.1 to 10.
At such a ratio, the polymers show pronounced bacteria-repellent properties. Particularly pronounced cellproliferation-inhibiting properties are additionally achieved if the ratio mentioned is 0.2 to 3, more preferably 0.4 to 3, and in particular 0.4 to 2. The coated surfaces remarkably show bacteria-repellent but cell proliferation-promoting properties if the molar ratio is 2 to 10, preferably 3 to 10, and in particular 3 to 5. A polymer is cell proliferation-promoting in the context of the invention if the adhesion and o.z. 5238 multiplication of mammalian cells is improved or at any rate less severely impaired than the adhesion and multiplication of bacteria.
6. Further monomer~ (monomers E) In addition to monomers A to D, the polymers according to the invention can comprise one or more further olefinically unsaturated monomers (monomers E), which are free from carboxyl, carboxylate, sulfuric acid, sulfate, sulfonic acid, sulfonate and acid anhydride groups. Whether the polymer is water-soluble or only swellable depends on their nature and amount of the monomers including the monomer E. If the polymer is to be applied as a coating composition from an aqueous medium, the co-use of hydrophilic monomers, for example containing hydroxyl groups, is easily possible.
Monomers E containing hydroxyl groups or amino groups are also beneficial for the covalent bonding of the polymer according to the invention to substrates. It is easy to determine by preliminary experiments which monomers E the polymer according to the invention can comprise in what amounts so that it meets the particular requirements imposed, for example in respect of its mechanical properties.
Monomers E which can be used are, for example ~meth)acrylic acid derivatives, preferably alkyl, hydroxyalkyl, hydroxyalkoxyalkyl, aminoalkyl, N,N-dialkylaminoalkyl esters having 1 to 10 carbon atoms in each alkyl or alkoxy moiety. Examples include ethyl acrylate, isobutyl acrylate, 2-ethylhexyl acrylate, 2-hydroxyethyl o.z. 5238 acrylate, 2-(2'-hydroxyethoxy)ethyl acrylate, 2-hydroxy-1-methylethyl acrylate, 2-N,N-dimethylaminoethyl acrylate, n-propyl methacrylate, 2-hydroxyethyl methacrylate, 2-(2'-hydroxyethoxy)ethyl methacrylate, 2-hydroxy-1-methylethyl methacrylate, 2-N,N-dimethylaminoethyl methacrylate, diethylene glycol monomethacrylate, (meth)acrylamide and (meth)acrylonitrile. Another group of the monomers E may be olefinically unsaturated amine5, such as vinylamine and allylamine: vinyl ketones, such as vinyl ethyl ketone;
olefins, such as 1-butene, l-hexene and 1-octene;
vinylaromatics, such as styrene, ~-methylstyrene and vinyltoluene; and vinylsiloxanes.
Monomers E containing hydroxyl groups or amino groups are also beneficial for the covalent bonding of the polymer according to the invention to substrates. It is easy to determine by preliminary experiments which monomers E the polymer according to the invention can comprise in what amounts so that it meets the particular requirements imposed, for example in respect of its mechanical properties.
Monomers E which can be used are, for example ~meth)acrylic acid derivatives, preferably alkyl, hydroxyalkyl, hydroxyalkoxyalkyl, aminoalkyl, N,N-dialkylaminoalkyl esters having 1 to 10 carbon atoms in each alkyl or alkoxy moiety. Examples include ethyl acrylate, isobutyl acrylate, 2-ethylhexyl acrylate, 2-hydroxyethyl o.z. 5238 acrylate, 2-(2'-hydroxyethoxy)ethyl acrylate, 2-hydroxy-1-methylethyl acrylate, 2-N,N-dimethylaminoethyl acrylate, n-propyl methacrylate, 2-hydroxyethyl methacrylate, 2-(2'-hydroxyethoxy)ethyl methacrylate, 2-hydroxy-1-methylethyl methacrylate, 2-N,N-dimethylaminoethyl methacrylate, diethylene glycol monomethacrylate, (meth)acrylamide and (meth)acrylonitrile. Another group of the monomers E may be olefinically unsaturated amine5, such as vinylamine and allylamine: vinyl ketones, such as vinyl ethyl ketone;
olefins, such as 1-butene, l-hexene and 1-octene;
vinylaromatics, such as styrene, ~-methylstyrene and vinyltoluene; and vinylsiloxanes.
7. Preparation of the polymers accordinq to the invention The polymers may be prepared in the customary manner by polymerization initiated by free radicals, preferably by solution or emulsion polymerization. Suitable solvents are, for example, ketones, such as acetone, methyl ethyl ketone and cyclohexanone; ethers, such as diethyl ether, tetrahydrofuran and dioxane; alcohols, such as methanol, ethanol, n- and iso-propanol, n- and iso-butanol and cyclohexanol; strongly polar solvents, such as dimethylformamide, dimethylacetamide and dimethylsulfoxide; hydrocarbons, such as heptane, cyclohexane, benzene and toluene; halogenated hydrocarbons, such as methylene chloride and chloroform; esters, such as ethyl acetate, propyl acetate and amyl acetate; and nitriles, such as acetonitrile; or mixtures of these solvents.
Suitable polymerization initiators are, for example, o.Z. 5238 azonitriles, alkyl peroxides, acyl peroxides, hydroperoxides, peroxyketones, peroxyesters and percarbonates, and all the customary photoinitiators. The polymerization is initiated by means of heat, for example by heating to 60 to 100~C, or by exposure to radiation of an appropriate wavelength. When the exothermic polymerization reaction has ended, the polymer is separated off from the solvent in the customary manner, for example by precipitation by means of n-hexane. Monomeric or oligomeric constituents can be removed by extraction with a suitable solvent, for example with water or aqueous alcohol.
Instead of monomers C and D, it is also possible to employ monomers having functional groups which may be converted into the functional groups characteristic of monomers C and D after the polymerization. Thus, carboxylic ester groups can be converted into carboxylate groups by treatment with aqueous or aqueous-alcoholic alkali, or carboxylic ester, carboxamide or nitrile groups can be converted into carboxyl groups by hydrolysis in an acid medium. As already mentioned, the ratio of carboxyl to carboxylate groups or of sulfonic acid to sulfonate groups or sulfuric acid to sulfate groups can furthermore be modified in the desired manner with alkaline or acid reagents after the polymerization.
The ratio of the amounts in which monomers A to D
are employed can vary within wide limits. Advantageously, the proportion of monomer A, maleic anhydride, is 15 to 50 mol~, preferably 35 to 50 mol~; the proportion of monomer B is O.Z. 5238 likewise 15 to 50 mol%, preferably 35 to 50 mol%; the proportion of monomer C is 0.5 to 30 mol~, preferably 0.5 to 15 mol%; and the proportion of monomer D is likewise 0.5 to 30 mol~, preferably 0.5 to 15 mol~. If the polymer according to the invention comprises further monomers E, the proportion thereof is as a rule 0.5 to 69 mol~, preferably 0.5 to 30 mol%.
It is preferred that conditions of the preparation of the copolymers are chosen such that the units of maleic anhydride in the resulting copolymers are in a carboxylic acid anhydride form, for example, by minimizing use of water.
Suitable polymerization initiators are, for example, o.Z. 5238 azonitriles, alkyl peroxides, acyl peroxides, hydroperoxides, peroxyketones, peroxyesters and percarbonates, and all the customary photoinitiators. The polymerization is initiated by means of heat, for example by heating to 60 to 100~C, or by exposure to radiation of an appropriate wavelength. When the exothermic polymerization reaction has ended, the polymer is separated off from the solvent in the customary manner, for example by precipitation by means of n-hexane. Monomeric or oligomeric constituents can be removed by extraction with a suitable solvent, for example with water or aqueous alcohol.
Instead of monomers C and D, it is also possible to employ monomers having functional groups which may be converted into the functional groups characteristic of monomers C and D after the polymerization. Thus, carboxylic ester groups can be converted into carboxylate groups by treatment with aqueous or aqueous-alcoholic alkali, or carboxylic ester, carboxamide or nitrile groups can be converted into carboxyl groups by hydrolysis in an acid medium. As already mentioned, the ratio of carboxyl to carboxylate groups or of sulfonic acid to sulfonate groups or sulfuric acid to sulfate groups can furthermore be modified in the desired manner with alkaline or acid reagents after the polymerization.
The ratio of the amounts in which monomers A to D
are employed can vary within wide limits. Advantageously, the proportion of monomer A, maleic anhydride, is 15 to 50 mol~, preferably 35 to 50 mol~; the proportion of monomer B is O.Z. 5238 likewise 15 to 50 mol%, preferably 35 to 50 mol%; the proportion of monomer C is 0.5 to 30 mol~, preferably 0.5 to 15 mol%; and the proportion of monomer D is likewise 0.5 to 30 mol~, preferably 0.5 to 15 mol~. If the polymer according to the invention comprises further monomers E, the proportion thereof is as a rule 0.5 to 69 mol~, preferably 0.5 to 30 mol%.
It is preferred that conditions of the preparation of the copolymers are chosen such that the units of maleic anhydride in the resulting copolymers are in a carboxylic acid anhydride form, for example, by minimizing use of water.
8. Coating of ~ubstrate~ with polymers according to the invention The invention furthermore relates to a process for coating substrates, in particular polymer substrates, in which the polymer according to the invention is bonded covalently to the substrate, for which reactive groups both in the polymer according to the invention and on the polymer substrate are required. The invention furthermore relates to products of polymer materials, ceramic or metal coated completely or partly with the polymers according to the invention.
The most diverse polymer substrates can be coated with the polymer according to the invention. Suitable polymers are, for example, polyamides, such as polyamide-6, polyamide-12, polyamide-6,6 and polyamide 6,12; polyurethanes of the most diverse diisocyanates and polyols and polyether-and polyester-polyols; polyether-block amides; polyester-block o.Z. 5238 amides; polyether-ester-amides; polyesters of aromatic dicarboxylic acids and varlous aliphatic or cycloaliphatic diols; and furthermore polyvinyl chloride, polystyrene, polyacrylates, polymethacrylates, polyethers, polycarbonates, polyolefins, silicones and polytetrafluoroethylene.
The polymer substrates mentioned often contain groups, such as carboxyl, amino or hydroxyl groups, which are helpful for covalent bonding of the coating polymer.
Alternatively, such groups can be generated on the surface of the polymer, for which a large number of known methods are available. Thus, o.z. 5238 corresponding monomers can be copolymerized or standard polymers can be modified, for example by treatment with acids or bases; irradiation with UV light, electron beams or x-rays; treatment with high-frequency or micro-wave plasma; or flaming. Primers with reacting groups can furthermore s also be applied to poiymers which do not originally contribute reactive groups and have not been subjected to any of the treatments mentioned or similar treatrnents. Suitable primers are, for example, polyisocyanates, such as tolylene diisocyanate, hexamethylene diisocyanate, diphenyl-methane 4,4'-diisocyanate, dicycloxymethane 4,4'~iisocyanate and iso-10 phorone diisocyanate; polyamines, such as ethy~enediamine, triethylene-diamine, 1,3-propylenediamine, 1,4-butylenediamine and 1,6-hexamethyle-nediamine; polyaldehydes, such as su¢cinaldehyde, adipaldehyde and terephthalaldehyde; and polyepoxides, such as ethylene glycol diglycidyl ether and 1,3-propylene glycol diglycidyl ether 15 A pretreatment with a suitab~e primer also allows covalent bonding of the coating polymer according to the invention to inorganic substrates, such as ceramic or metal, for example to highgade steel.
There are numerous possibilities for covalent bonding of the coating polymer to a polymer substrate or a primer. Thus, carboxylic acid an-2 o hydride groups of the co~ti ~y polymer ¢an react with amino groups on thesurface of the polymer substrate, which can have been generated, for example, (i) by NH3 plasma, (ii) by treatment of a polyamide or polyuretha-ne with alkali, (iii) by hydrolysis of copol~",efi~ed NCO groups or NCO
groups introduc~d by priming with a polyisocyanate or (iv) by priming with 25 an alkylenediamine. Alternatively, for e~.a"lplE, NCO groups on the sub-strate polymer which are excess NCO groups from the synthesis of a polyurethane or formed by treatment of a polymer substrate having hydroxyl or amino groups on the surface with a polyisocyanate (if appropriate in blocked form) as a primer, can react with hydroxyl groups in 30 the coating polymer, which have been introduced into the molecule, for example, by copolymeri~a~i~" of a mon~mer E c~ntaining hydroxyl groups.
O. Z 5238 A third variant comprises linking a polymer substrate having hydroxyl or amino groups onto the surface with a coating polymer which contains copolymerized amino or hydroxyl groups with the aid of a diepoxide. Furthermore, dicarboxylic acid dihalides can be employed as primers if the polymer substrate and coating polymers contain COCI-reactive groups. All these reactions are known per se and further linking mechanisms will readily become apparent to a person skilled in the art, depending on the nature of the functionality of the reactive groups on the polymer substrate, in the coating polymer and, where appropriate, in the primer.
The primer and coating polymer are expediently applied in solution to the polymer substrate. Suitable solvents are, for example, water; alcohols, such as methanol, ethanol and n-butanol; ketones, such as acetone, butanone (methyl ethyl ketone) and cyclohexanone; esters, such as methyl acetate, methyl propionate, ethyl acetate and n-butyl acetate; ethers, such as ethylene glycol diethyl ether and tetrahydrofuran; and aromatic hydrocarbons, such as toluene and xylene. The choice of solvent depends on the nature of the polymer substrate, which must not be dissolved, but should certainly be swollen. If water or alcohols are employed as the solvent, the NCO groups must be protected in the customary manner, for example with methyl ethyl ketoxime, from polyisocyanates envisaged as the primer.
If a polymer substrate is treated with a primer before being coated, the solution thereof is expediently o. z. 5238 allowed to act on the substrate for some time, for example 5 minutes to 2 hours, if appropriate at elevated temperature, for example up to 60~C, and the solvent is then evaporated, if appropriate in vacuo and/or at elevated temperature.
The known processes, such as dipping, spraying, brushing, knife-coating and spin-coating, are suitable for coating the polymer substrate. After the coating operations, the solvent is in turn evaporated. For covalent linking of the coating polymer with the substrate, the coated substrate is expediently kept at elevated temperature, for example at 50 to 90~C, for some time, for example 5 minutes to 2 hours. If a blocked isocyanate is to effect the linking, correspondingly higher temperatures may be necessary.
Coating with the polymers according to the invention renders it possible to further use known and proven materials and production processes. This is particularly important if the mechanical properties of the materials are of great importance, or the production plants for the existing production processes require high investments.
The most diverse polymer substrates can be coated with the polymer according to the invention. Suitable polymers are, for example, polyamides, such as polyamide-6, polyamide-12, polyamide-6,6 and polyamide 6,12; polyurethanes of the most diverse diisocyanates and polyols and polyether-and polyester-polyols; polyether-block amides; polyester-block o.Z. 5238 amides; polyether-ester-amides; polyesters of aromatic dicarboxylic acids and varlous aliphatic or cycloaliphatic diols; and furthermore polyvinyl chloride, polystyrene, polyacrylates, polymethacrylates, polyethers, polycarbonates, polyolefins, silicones and polytetrafluoroethylene.
The polymer substrates mentioned often contain groups, such as carboxyl, amino or hydroxyl groups, which are helpful for covalent bonding of the coating polymer.
Alternatively, such groups can be generated on the surface of the polymer, for which a large number of known methods are available. Thus, o.z. 5238 corresponding monomers can be copolymerized or standard polymers can be modified, for example by treatment with acids or bases; irradiation with UV light, electron beams or x-rays; treatment with high-frequency or micro-wave plasma; or flaming. Primers with reacting groups can furthermore s also be applied to poiymers which do not originally contribute reactive groups and have not been subjected to any of the treatments mentioned or similar treatrnents. Suitable primers are, for example, polyisocyanates, such as tolylene diisocyanate, hexamethylene diisocyanate, diphenyl-methane 4,4'-diisocyanate, dicycloxymethane 4,4'~iisocyanate and iso-10 phorone diisocyanate; polyamines, such as ethy~enediamine, triethylene-diamine, 1,3-propylenediamine, 1,4-butylenediamine and 1,6-hexamethyle-nediamine; polyaldehydes, such as su¢cinaldehyde, adipaldehyde and terephthalaldehyde; and polyepoxides, such as ethylene glycol diglycidyl ether and 1,3-propylene glycol diglycidyl ether 15 A pretreatment with a suitab~e primer also allows covalent bonding of the coating polymer according to the invention to inorganic substrates, such as ceramic or metal, for example to highgade steel.
There are numerous possibilities for covalent bonding of the coating polymer to a polymer substrate or a primer. Thus, carboxylic acid an-2 o hydride groups of the co~ti ~y polymer ¢an react with amino groups on thesurface of the polymer substrate, which can have been generated, for example, (i) by NH3 plasma, (ii) by treatment of a polyamide or polyuretha-ne with alkali, (iii) by hydrolysis of copol~",efi~ed NCO groups or NCO
groups introduc~d by priming with a polyisocyanate or (iv) by priming with 25 an alkylenediamine. Alternatively, for e~.a"lplE, NCO groups on the sub-strate polymer which are excess NCO groups from the synthesis of a polyurethane or formed by treatment of a polymer substrate having hydroxyl or amino groups on the surface with a polyisocyanate (if appropriate in blocked form) as a primer, can react with hydroxyl groups in 30 the coating polymer, which have been introduced into the molecule, for example, by copolymeri~a~i~" of a mon~mer E c~ntaining hydroxyl groups.
O. Z 5238 A third variant comprises linking a polymer substrate having hydroxyl or amino groups onto the surface with a coating polymer which contains copolymerized amino or hydroxyl groups with the aid of a diepoxide. Furthermore, dicarboxylic acid dihalides can be employed as primers if the polymer substrate and coating polymers contain COCI-reactive groups. All these reactions are known per se and further linking mechanisms will readily become apparent to a person skilled in the art, depending on the nature of the functionality of the reactive groups on the polymer substrate, in the coating polymer and, where appropriate, in the primer.
The primer and coating polymer are expediently applied in solution to the polymer substrate. Suitable solvents are, for example, water; alcohols, such as methanol, ethanol and n-butanol; ketones, such as acetone, butanone (methyl ethyl ketone) and cyclohexanone; esters, such as methyl acetate, methyl propionate, ethyl acetate and n-butyl acetate; ethers, such as ethylene glycol diethyl ether and tetrahydrofuran; and aromatic hydrocarbons, such as toluene and xylene. The choice of solvent depends on the nature of the polymer substrate, which must not be dissolved, but should certainly be swollen. If water or alcohols are employed as the solvent, the NCO groups must be protected in the customary manner, for example with methyl ethyl ketoxime, from polyisocyanates envisaged as the primer.
If a polymer substrate is treated with a primer before being coated, the solution thereof is expediently o. z. 5238 allowed to act on the substrate for some time, for example 5 minutes to 2 hours, if appropriate at elevated temperature, for example up to 60~C, and the solvent is then evaporated, if appropriate in vacuo and/or at elevated temperature.
The known processes, such as dipping, spraying, brushing, knife-coating and spin-coating, are suitable for coating the polymer substrate. After the coating operations, the solvent is in turn evaporated. For covalent linking of the coating polymer with the substrate, the coated substrate is expediently kept at elevated temperature, for example at 50 to 90~C, for some time, for example 5 minutes to 2 hours. If a blocked isocyanate is to effect the linking, correspondingly higher temperatures may be necessary.
Coating with the polymers according to the invention renders it possible to further use known and proven materials and production processes. This is particularly important if the mechanical properties of the materials are of great importance, or the production plants for the existing production processes require high investments.
9. Products according to the invention The polymers according to the invention offer particular advantages in the case of shaped articles which are moved along against sensitive surfaces. This is the case, for example, with catheters and tubes according to the invention, which subject the internal walls of vessels, such as veins and arteries, to minimal stress as a result of low frictional resistance.
O.z. 523~3 The shaped articles produced according to the invention are intended in particular for use in the fields of foodstuffs and tobacco, the water industry, bioengineering, hygiene provision and, in particular, medicine. For example, the polymers described herein can be used for the production of textiles, apparatus, pipes and tubes, condoms, packagings and medical articles coated with a polymer according to the invention on plastic, ceramic or metal as the substrate.
Medical articles are, for example, implants or aids, such as drainage, guide wires, cannulas, intraocular lenses, contact lenses, stents, vascular prostheses, joint prostheses, dialysis membranes and suture materials. Preferred products are catheters or tubes for medical use.
The following examples are intended to illustrate the invention further, but not to limit its scope as described in the patent claims.
Examples Measurement of the adhe~ion of bacteria to coated stan~rd films via ATP (static) After adsorption of microbe cells on a standard film having a coating of a particular polymer according to the invention, the non-adhering bacteria are rinsed off with sterile PBS buffer solution. The bacteria constituent adenosine triphosphate (ATP is extracted in the customary manner from the bacteria adhering to the film and determined in a bioluminometric 0. Z. 5238 assay using a commercJally available test combination. The number of ~ Iight pulses measured is proportional to the number of adhering bacteria. A
non-coated standard film serves as the reference sample. For example, if a polyamide 12 film is coated with a polymer according to the invention, a non-coated polyamide 12 film serves as the referencs sample. To calcula-te the inhibition of the adhe$ion of bacteria, the adsorption on the referen-ce film is set at 100. The inhibition is the difference between the adsorption on the coated and that on the non~oated standard fllm.
Measurement of the frictional resistance A non~oated standard film is glued onto a pane of glass, the angle of inclination of which to the horizontal is infinitely adjustable and can be measured. A piece of the coated standard film is clamped with the coated side facing outward in the clamping device of a rectangular test weight (6 cm x 4 cm, weight 100 9). The coated and the non-coated standard film are moistened to dripping wet, and the test weight is placsd on the glass plate glued with the standard film. The angle of inclination of the glass plate is increased, continu~sly and without jerking, at about 20 Glminute, sta, li"~ at 0~, until the weight mounted on it moves. The angle established at this point in time is recorded. Its tang~nt is the coefficient of adhesive 2 0 friction.
Example 1 100 ml of dimethyl sulfoxido (DMS0) are introduced under an inert gas (nitrogen) into a 1 1 five-nedced flask provided with a stirrer, refluxed condenser and four dropping funnels. A solution (feed 1 ) is prepared from 100 ml of DMS0 and 70 g of maleic anhydride (MA) and is introduced into dropping funnel 1. Dropping funnel 2 is fllled with 6Z ml of vinyl methyl ether (VME; feed 2). Dropping funnel 3 contains a solution (feed 3) of 7.2 ml of acrylic acid (M), 19.ô g of sodium styrenesulfonate (NaSS) and 70 mJ of DMS0. 1.5 9 of azoisobutyronitrile in 20 ml of DMS0 (feed 4) are O. Z. 5238 introduced into dropping funnel 4. 8 ml of feed 1 from dropping funnel 1 and in each case S ml of feed 2, 3 and 4 from dropping funnels 2, 3 and 4 are metered into the flasl~. Thereafter, the mixture is heated to 70~C. After a further 10 minutes, feed t, 2 and 3 are metered in over a period of 3.5 s hours, while feed 4 is metered in over a period of 4 hours. When the addition has ended, the reaction solution is kept at 70CC for a further 4 hours. The quaternary polymer is precipitated out by stirring into 2 1 of n-hexane and washed with water. NMR analysis of the quatemary polymer shows a composition of MA 43.2 mol%
VME 45.1 mol%
M 6.6 mol%
NaSS 5.1 mol%
The molar ratio of COOH or COO- to SO3- iS 1.3.
l 5 To measure the adhesion of h3Ctl~ ia, a polyamide 12 film is coated with the quatemary polymer. For this, a solution of the quatemary polymer in dimethylsulfoxide (20 g/l) is prepared. This solution is sprayed onto the polyamide 12 film and the solvent is allowed to evaporate. Measurement of bacterial adso" tion with Kl~bsiella Dneu~or~ showed a reduction by 92% compared with the non~oated polyamide 12 film.
To measure the coefficient of fnction, the film coated with the quaternary polymer, as described, was glued to the test weight. Measurement of the fricSional resistance with respect to a non-coated polyamide 12 film gave a cGerri~ien~ of adhesive friction of 0.05. The coefficient of adhesive friction of two non~oated polyamide 12 films is 0.42.
Example 2 The procedure is as in Example l, but feed 3 is a solution of 9 ml of acrvlic O, Z. 5238 ~44~-ha9 acid (M) 14.4 9 of sodium styrenesulfonate (Na~) an~ f~J ml Ot L~M~U.
NMR analysis of the quaternary polymer gives a composition of MA 42.9 mol%
VME 44.~ mol%
M 7.5 mol%
NaSS 4.7 mol%
The molar ratio of COOI I or COO- to S O3-is 1.6.
Measurement of the adhesion of bacteria with Klebsiella Pneumoniae gives a reduction by 95% compared with a non-coated polyamide 12 film.
The coe~cient of adhesive friction is 0.06.
Example 3 A polyamide 12 film (~ cm x 6 cm) is immersed in a 1% strength by weight solution of diphenylme~harle diisocyanat~ in ethyl methyl ketone at room temperature under an inert gas (argon) for 1 hour. The film is removed and dried in a drying cabinet at 60~C for a period of 30 minutes. The dried film is then i"""ersed in a 2% strength by weight solution of the polymer from Exa,nple 1 in dimethyl sulfoxide at room temperature for 4 seconds. The film is then dried first in a drying cabinet at 60~C for 1 hour and then at 70~ v under a pressure of 1 Mbar for 5 hours. Thereafter the film is 2 0 placed in water at 25 C for 3 hours and dried at 6C~ C for 24 hours.
The inhibition of the adsor~,ti~" of Klebsiella pneumoniae. Iike that of the other abovementioned strains of bacteria is > 92%. The coefficient of adhesive friction is 0.05.
Similar results are achieved if the polymer of Example 2 is bonded cova-2 5 lently to a polyamide 12 film in an analogous manner.
O, Z. 5238 23443-64g
O.z. 523~3 The shaped articles produced according to the invention are intended in particular for use in the fields of foodstuffs and tobacco, the water industry, bioengineering, hygiene provision and, in particular, medicine. For example, the polymers described herein can be used for the production of textiles, apparatus, pipes and tubes, condoms, packagings and medical articles coated with a polymer according to the invention on plastic, ceramic or metal as the substrate.
Medical articles are, for example, implants or aids, such as drainage, guide wires, cannulas, intraocular lenses, contact lenses, stents, vascular prostheses, joint prostheses, dialysis membranes and suture materials. Preferred products are catheters or tubes for medical use.
The following examples are intended to illustrate the invention further, but not to limit its scope as described in the patent claims.
Examples Measurement of the adhe~ion of bacteria to coated stan~rd films via ATP (static) After adsorption of microbe cells on a standard film having a coating of a particular polymer according to the invention, the non-adhering bacteria are rinsed off with sterile PBS buffer solution. The bacteria constituent adenosine triphosphate (ATP is extracted in the customary manner from the bacteria adhering to the film and determined in a bioluminometric 0. Z. 5238 assay using a commercJally available test combination. The number of ~ Iight pulses measured is proportional to the number of adhering bacteria. A
non-coated standard film serves as the reference sample. For example, if a polyamide 12 film is coated with a polymer according to the invention, a non-coated polyamide 12 film serves as the referencs sample. To calcula-te the inhibition of the adhe$ion of bacteria, the adsorption on the referen-ce film is set at 100. The inhibition is the difference between the adsorption on the coated and that on the non~oated standard fllm.
Measurement of the frictional resistance A non~oated standard film is glued onto a pane of glass, the angle of inclination of which to the horizontal is infinitely adjustable and can be measured. A piece of the coated standard film is clamped with the coated side facing outward in the clamping device of a rectangular test weight (6 cm x 4 cm, weight 100 9). The coated and the non-coated standard film are moistened to dripping wet, and the test weight is placsd on the glass plate glued with the standard film. The angle of inclination of the glass plate is increased, continu~sly and without jerking, at about 20 Glminute, sta, li"~ at 0~, until the weight mounted on it moves. The angle established at this point in time is recorded. Its tang~nt is the coefficient of adhesive 2 0 friction.
Example 1 100 ml of dimethyl sulfoxido (DMS0) are introduced under an inert gas (nitrogen) into a 1 1 five-nedced flask provided with a stirrer, refluxed condenser and four dropping funnels. A solution (feed 1 ) is prepared from 100 ml of DMS0 and 70 g of maleic anhydride (MA) and is introduced into dropping funnel 1. Dropping funnel 2 is fllled with 6Z ml of vinyl methyl ether (VME; feed 2). Dropping funnel 3 contains a solution (feed 3) of 7.2 ml of acrylic acid (M), 19.ô g of sodium styrenesulfonate (NaSS) and 70 mJ of DMS0. 1.5 9 of azoisobutyronitrile in 20 ml of DMS0 (feed 4) are O. Z. 5238 introduced into dropping funnel 4. 8 ml of feed 1 from dropping funnel 1 and in each case S ml of feed 2, 3 and 4 from dropping funnels 2, 3 and 4 are metered into the flasl~. Thereafter, the mixture is heated to 70~C. After a further 10 minutes, feed t, 2 and 3 are metered in over a period of 3.5 s hours, while feed 4 is metered in over a period of 4 hours. When the addition has ended, the reaction solution is kept at 70CC for a further 4 hours. The quaternary polymer is precipitated out by stirring into 2 1 of n-hexane and washed with water. NMR analysis of the quatemary polymer shows a composition of MA 43.2 mol%
VME 45.1 mol%
M 6.6 mol%
NaSS 5.1 mol%
The molar ratio of COOH or COO- to SO3- iS 1.3.
l 5 To measure the adhesion of h3Ctl~ ia, a polyamide 12 film is coated with the quatemary polymer. For this, a solution of the quatemary polymer in dimethylsulfoxide (20 g/l) is prepared. This solution is sprayed onto the polyamide 12 film and the solvent is allowed to evaporate. Measurement of bacterial adso" tion with Kl~bsiella Dneu~or~ showed a reduction by 92% compared with the non~oated polyamide 12 film.
To measure the coefficient of fnction, the film coated with the quaternary polymer, as described, was glued to the test weight. Measurement of the fricSional resistance with respect to a non-coated polyamide 12 film gave a cGerri~ien~ of adhesive friction of 0.05. The coefficient of adhesive friction of two non~oated polyamide 12 films is 0.42.
Example 2 The procedure is as in Example l, but feed 3 is a solution of 9 ml of acrvlic O, Z. 5238 ~44~-ha9 acid (M) 14.4 9 of sodium styrenesulfonate (Na~) an~ f~J ml Ot L~M~U.
NMR analysis of the quaternary polymer gives a composition of MA 42.9 mol%
VME 44.~ mol%
M 7.5 mol%
NaSS 4.7 mol%
The molar ratio of COOI I or COO- to S O3-is 1.6.
Measurement of the adhesion of bacteria with Klebsiella Pneumoniae gives a reduction by 95% compared with a non-coated polyamide 12 film.
The coe~cient of adhesive friction is 0.06.
Example 3 A polyamide 12 film (~ cm x 6 cm) is immersed in a 1% strength by weight solution of diphenylme~harle diisocyanat~ in ethyl methyl ketone at room temperature under an inert gas (argon) for 1 hour. The film is removed and dried in a drying cabinet at 60~C for a period of 30 minutes. The dried film is then i"""ersed in a 2% strength by weight solution of the polymer from Exa,nple 1 in dimethyl sulfoxide at room temperature for 4 seconds. The film is then dried first in a drying cabinet at 60~C for 1 hour and then at 70~ v under a pressure of 1 Mbar for 5 hours. Thereafter the film is 2 0 placed in water at 25 C for 3 hours and dried at 6C~ C for 24 hours.
The inhibition of the adsor~,ti~" of Klebsiella pneumoniae. Iike that of the other abovementioned strains of bacteria is > 92%. The coefficient of adhesive friction is 0.05.
Similar results are achieved if the polymer of Example 2 is bonded cova-2 5 lently to a polyamide 12 film in an analogous manner.
O, Z. 5238 23443-64g
Claims (31)
1. A copolymer which is made of repeating units derived from monomers consisting essentially of:
(A) maleic anhydride;
(B) at least one vinyl alkyl ether having an alkyl radical of 1 to 6 carbon atoms;
(C) at least one vinyl monomer containing a carboxyl or carboxylate group; and (D) at least one vinyl monomer containing a sulfuric acid, sulfate, sulfonic acid or sulfonate group, wherein the monomers (C) and (D) may be replaced by at least one vinyl monomer containing both (i) a carboxyl or carboxylate group and (ii) a sulfuric acid sulfate, sulfonic acid or sulfonate group.
(A) maleic anhydride;
(B) at least one vinyl alkyl ether having an alkyl radical of 1 to 6 carbon atoms;
(C) at least one vinyl monomer containing a carboxyl or carboxylate group; and (D) at least one vinyl monomer containing a sulfuric acid, sulfate, sulfonic acid or sulfonate group, wherein the monomers (C) and (D) may be replaced by at least one vinyl monomer containing both (i) a carboxyl or carboxylate group and (ii) a sulfuric acid sulfate, sulfonic acid or sulfonate group.
2. The copolymer according to claim 1, which contains sulfate or sulfonate groups and carboxyl or carboxylate groups.
3. The copolymer according to claim 2, in which the carboxylate and sulfonate groups when contained, have a sodium or ammonium ion as their counterion.
4. The copolymer according to any one of claims 1 to 3, in which monomer B is vinyl methyl ether.
5. The copolymer according to any one of claims 1 to 4, in which monomer C has the general formula:
(C n H2n-q-x)(COOR1)x (I) in which:
n is an integer of from 2 to 5;
x is 1 or 2;
q is 0 or 2; and R1 in each case independently is -H, an alkali metal ion or an ammonium ion of the formula N(R5)4+ in which R5 independently is a hydrogen atom or a hydrocarbon radical having 1 to 20 carbon atoms.
(C n H2n-q-x)(COOR1)x (I) in which:
n is an integer of from 2 to 5;
x is 1 or 2;
q is 0 or 2; and R1 in each case independently is -H, an alkali metal ion or an ammonium ion of the formula N(R5)4+ in which R5 independently is a hydrogen atom or a hydrocarbon radical having 1 to 20 carbon atoms.
6. The polymer according to any one of claims 1 to 4, in which monomer C has the general formula:
(C6H6-b-c-d)[(C n H2n-1-q-x)(COOR1)x]b R3c(OH)d (II) (in which:
n is an integer of from 2 to 5;
x is 1 or 2;
q is 0 or 2;
R1 in each case independently is -H, an alkali metal ion or an ammonium ion of the formula N(R5)4+ in which R5 independently is a hydrogen atom or a hydrocarbon radical having 1 to 20 carbon atoms ;
b is 1, 2 or 3;
c is 0, 1, 2 or 3;
d is 0, 1, 2 or 3; and R3 in each case independently is C1-4-alkyl, -NH2, -COOH, -SO3H, -OSO3H, -OPO(OH)2, -PO(OH)2, -OP(OH)2-OPO(O-)OCH2-CH2-N+(CH3)3, -PO(O-)O-CH2-CH2-N+(CH3)3, -OP(O-)OCH2-CH2-N+(CH3)3 or a salt thereof;
with the proviso that the total of a, c and d is not more than 6.
(C6H6-b-c-d)[(C n H2n-1-q-x)(COOR1)x]b R3c(OH)d (II) (in which:
n is an integer of from 2 to 5;
x is 1 or 2;
q is 0 or 2;
R1 in each case independently is -H, an alkali metal ion or an ammonium ion of the formula N(R5)4+ in which R5 independently is a hydrogen atom or a hydrocarbon radical having 1 to 20 carbon atoms ;
b is 1, 2 or 3;
c is 0, 1, 2 or 3;
d is 0, 1, 2 or 3; and R3 in each case independently is C1-4-alkyl, -NH2, -COOH, -SO3H, -OSO3H, -OPO(OH)2, -PO(OH)2, -OP(OH)2-OPO(O-)OCH2-CH2-N+(CH3)3, -PO(O-)O-CH2-CH2-N+(CH3)3, -OP(O-)OCH2-CH2-N+(CH3)3 or a salt thereof;
with the proviso that the total of a, c and d is not more than 6.
7. The polymer according to any one of claims 1 to 6, in which monomer D has the general formula:
(C n H2n-q-x)(SO3R1)x, (III) (in which:
n is an integer of from 2 to 5;
x is 1 or 2;
q is 0 or 2; and R1 in each case independently is -H, an alkali metal ion or an ammonium ion of the formula N(R5)4+ in which R5 independently is a hydrogen atom or a hydrocarbon radical having 1 to 20 carbon atoms).
(C n H2n-q-x)(SO3R1)x, (III) (in which:
n is an integer of from 2 to 5;
x is 1 or 2;
q is 0 or 2; and R1 in each case independently is -H, an alkali metal ion or an ammonium ion of the formula N(R5)4+ in which R5 independently is a hydrogen atom or a hydrocarbon radical having 1 to 20 carbon atoms).
8. The polymer according to any one of claims 1 to 6, in which monomer D has the general formula:
(C6H6-b-c-d)[(C n H2n-1-q-x)(SO3R1)x]b R3c(OH)d (IV) in which:
n is an integer of from 2 to 5;
x is 1 or 2;
q is 0 or 2;
R1 in each case independently is -H, an alkali metal ion or an ammonium ion of the formula N(R5)4+ in which R5 independently is a hydrogen atom or a hydrocarbon radical having 1 to 20 carbon atoms .
(C6H6-b-c-d)[(C n H2n-1-q-x)(SO3R1)x]b R3c(OH)d (IV) in which:
n is an integer of from 2 to 5;
x is 1 or 2;
q is 0 or 2;
R1 in each case independently is -H, an alkali metal ion or an ammonium ion of the formula N(R5)4+ in which R5 independently is a hydrogen atom or a hydrocarbon radical having 1 to 20 carbon atoms .
9. The polymer according to any one of claims 1 to 6, in which monomer D has the general formula:
(in which R1 is a hydrogen atom or a methyl radical, R2 is a divalent organic radical, or a single bond, R3 is -O- or -NH-, R4 is hydrogen, -SO3-Na+ or -SO3-N(R5)4+, in which the radicals R5 in each case independently are a hydrogen atom or an organic radical, and n is 4 or 5;
with the proviso that at least one of the substituents R4 is -SO3-Na+ or -SO3-N(R5)4+).
(in which R1 is a hydrogen atom or a methyl radical, R2 is a divalent organic radical, or a single bond, R3 is -O- or -NH-, R4 is hydrogen, -SO3-Na+ or -SO3-N(R5)4+, in which the radicals R5 in each case independently are a hydrogen atom or an organic radical, and n is 4 or 5;
with the proviso that at least one of the substituents R4 is -SO3-Na+ or -SO3-N(R5)4+).
10. The polymer according to any one of claims 1 to 8, which contains both (i) a carboxyl or carboxylate group and (ii) a sulfonic acid or sulfonate group.
11. The polymer according to claim 10, in which a molar ratio of the carboxyl or carboxylate group to the sulfonic acid or sulfonate group is 0.1 to 10.
12. The polymer according to claim 10, in which the molar ratio of the carboxyl or carboxylate group to the sulfonic acid or sulfonate group is 0.2 to 3.
13. The polymer according to claim 10, in which the molar ratio of the carboxyl or carboxylate group to the sulfonic acid or sulfonate group is 2 to 10.
14. The polymer according to claim 1, which consists essentially of repeating units derived from:
(A) maleic anhydride;
(B) vinyl methyl ether;
(C) at least one unsaturated carboxylic acid selected from the group consisting of acrylic acid, methacrylic acid, 4-vinylsalicylic acid, itaconic acid, vinylacetic acid, cinnamic acid, 4-vinylbenzoic acid, 2-vinylbenzoic acid, sorbic acid, caffeic acid, methylmaleic acid, crotonic acid, isocrotonic acid, fumaric acid, dimethylfumaric acid, methylfumaric acid, dihydroxymaleic acid, and allylacetic acid, or a salt thereof selected from the group consisting of sodium, ammonium, methylammonium, dimethylammonium, trimethylammonium, tetramethylammonium, dimethyl-1-n-octylammonium, dimethyl-1-n-octadecylammonium, dimethylbenzylammonium and dimethylanilinium salts; and (D) at least one monomer selected from the group consisting of sodium allylsulfonate, sodium methallylsulfonate, vinylsulfonic acid, sodium vinylsulfonate, 4-styrenesulfonic acid, 2-styrenesulfonic acid, sodium 2-styrenesulfonate, sodium 4-styrenesulfonate, sodium vinyltoluenesulfonate, dimethyl-1-n-octylammonium-4-styrenesulfonate, dimethyl-1-n-octylammonium-2-styrenesulfonate, sodium allyl sulfate and sodium methallyl sulfate.
(A) maleic anhydride;
(B) vinyl methyl ether;
(C) at least one unsaturated carboxylic acid selected from the group consisting of acrylic acid, methacrylic acid, 4-vinylsalicylic acid, itaconic acid, vinylacetic acid, cinnamic acid, 4-vinylbenzoic acid, 2-vinylbenzoic acid, sorbic acid, caffeic acid, methylmaleic acid, crotonic acid, isocrotonic acid, fumaric acid, dimethylfumaric acid, methylfumaric acid, dihydroxymaleic acid, and allylacetic acid, or a salt thereof selected from the group consisting of sodium, ammonium, methylammonium, dimethylammonium, trimethylammonium, tetramethylammonium, dimethyl-1-n-octylammonium, dimethyl-1-n-octadecylammonium, dimethylbenzylammonium and dimethylanilinium salts; and (D) at least one monomer selected from the group consisting of sodium allylsulfonate, sodium methallylsulfonate, vinylsulfonic acid, sodium vinylsulfonate, 4-styrenesulfonic acid, 2-styrenesulfonic acid, sodium 2-styrenesulfonate, sodium 4-styrenesulfonate, sodium vinyltoluenesulfonate, dimethyl-1-n-octylammonium-4-styrenesulfonate, dimethyl-1-n-octylammonium-2-styrenesulfonate, sodium allyl sulfate and sodium methallyl sulfate.
15. The polymer according to claim 14, which comprises, as copolymerized monomers, maleic anhydride, vinyl methyl ether, acrylic acid and sodium 2- or 4-styrenesulfonate.
16. The polymer according to claim 14 or 15, which comprises an additional monomer (E) selected from the group consisting of ethylacrylate, isobutyl acrylate, 2-ethylhexyl acrylate, 2-hydroxyethyl acrylate, 2-(2'-hydroxyethoxy)ethyl acrylate, 2-hydroxy-1-methylethyl acrylate, 2-N,N-dimethylaminoethyl acrylate, n-propyl methacrylate, 2-hydroxyethyl methacrylate, 2-(2'-hydroxyethoxy)ethyl methacrylate, 2-hydroxy-1-methylethyl methacrylate, 2-N,N- dimethylaminoethyl methacrylate, diethylene glycol monomethacrylate, (meth)acrylamide, (meth)acrylonitrile, vinylamine, allylamine, vinyl ethyl ketone, 1-butene, 1-hexene, 1-octene, styrene, .alpha.-methylstyrene and vinyltoluene.
17. A copolymer composed of repeating units of:
(A) 15 - 50 mol% of maleic anhydride;
(B) 15 - 50 mol% of at least one vinyl alkyl ether having an alkyl radical of 1 to 6 carbon atoms;
(C) 0.5 - 30 mol% of at least one ethylenically unsaturated mono- or dicarboxylic acid or a physiologically acceptable salt thereof;
(D) 0.5 - 30 mol% of at least one ethylenically unsaturated organic mono- or disulfuric acid or mono- or disulfonic acid or a physiologically acceptable salt thereof;
and (E) 0 or 0.5 - 69 mol% of at least one olefinically unsaturated monomer which is free from carboxyl, carboxylate, sulfuric acid, sulfate, sulfonic acid, sulfonate and acid anhydride groups, wherein the units of (C) and (D) may be replaced by units of at least one ethylenically unsaturated monomer (C + D) containing both (i) a carboxyl group or a physiologically acceptable salt thereof and (ii) a sulfuric or sulfonic acid group or a physiologically acceptable salt thereof, and wherein the units (A) of maleic anhydride are present in a carboxylic acid anhydride form in the copolymer.
(A) 15 - 50 mol% of maleic anhydride;
(B) 15 - 50 mol% of at least one vinyl alkyl ether having an alkyl radical of 1 to 6 carbon atoms;
(C) 0.5 - 30 mol% of at least one ethylenically unsaturated mono- or dicarboxylic acid or a physiologically acceptable salt thereof;
(D) 0.5 - 30 mol% of at least one ethylenically unsaturated organic mono- or disulfuric acid or mono- or disulfonic acid or a physiologically acceptable salt thereof;
and (E) 0 or 0.5 - 69 mol% of at least one olefinically unsaturated monomer which is free from carboxyl, carboxylate, sulfuric acid, sulfate, sulfonic acid, sulfonate and acid anhydride groups, wherein the units of (C) and (D) may be replaced by units of at least one ethylenically unsaturated monomer (C + D) containing both (i) a carboxyl group or a physiologically acceptable salt thereof and (ii) a sulfuric or sulfonic acid group or a physiologically acceptable salt thereof, and wherein the units (A) of maleic anhydride are present in a carboxylic acid anhydride form in the copolymer.
18. The copolymer of claim 17, lacking repeating units of the monomer (E).
19. The copolymer of claim 17 or 18, wherein the units (D) are of a physiologically acceptable salt of an ethylenically unsaturated organic monosulfonic acid; and the units (C) are of an ethylenically unsaturated monocarboxylic acid.
20. The copolymer of claim 17, 18 or 19, which has a molar ratio of the units (C) to the units (D) of 0.1 to 10.
21. A process for the preparation of a polymer according to any one of claims 1 to 20, which comprises subjecting monomers A, B, C and D, and optionally E, to free-radical polymerization.
22. The process according to claim 21, which comprises solution or emulsion polymerization of the monomers in the presence of azoisobutyronitrile.
23. The process according to claim 22, wherein DMSO is a solvent for solution polymerization.
24. The process according to claim 23, which comprises reacting maleic anhydride, vinyl methyl ether acrylic acid and sodium 2- or 4-styrenesulfonate.
25. A process for coating a substrate, which comprises covalently bonding a polymer as claimed in any one of claims 1 to 20 to the substrate by means of reactive groups both in the polymer and on the substrate.
26. The process according to claim 25, wherein the reactive groups are provided on the substrate by treatment with a primer having reactive groups.
27. The process according to claim 26, wherein the primer is selected from the group consisting of tolylene diisocyanate, hexamethylene diisocyanate, diphenylmethane 4,4'-diisocyanate, dicycloxymethane 4,4'-diisocyanate, isophorone diisocyanate, ethylenediamine, triethylenediamine, 1,3-propylenediamine, 1,4-butylenediamine, 1,6-hexamethylenediamine, succinaldehyde, adipaldehyde, terephthalaldehyde, ethylene glycol diglycidyl ether and 1,3-propylene glycol diglycidyl ether.
28. The use of a polymer according to any one of claims 1 to 20 for production of a product for use in the field of foodstuffs, tobacco, water industry, bioengineering, hygiene provision or medicine.
29. The use according to claim 28, wherein the product is a catheter or tube for medical use.
30. A shaped article which is coated completely or partly with a polymer as claimed in any one of claims 1 to 20, for use in the field of foodstuffs, luxury foods, water industry, bioengineering, hygiene provision or medicine.
31. The article as claimed in claim 30, which is a catheter or tube for medical use.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1997132587 DE19732587A1 (en) | 1997-07-29 | 1997-07-29 | Bioactive coating with a low-friction surface |
DE19732587.4 | 1997-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2244049A1 true CA2244049A1 (en) | 1999-01-29 |
Family
ID=7837225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2244049 Abandoned CA2244049A1 (en) | 1997-07-29 | 1998-07-27 | Bioactive coating with a low-friction surface |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0894504A2 (en) |
JP (1) | JPH11116640A (en) |
CA (1) | CA2244049A1 (en) |
DE (1) | DE19732587A1 (en) |
NO (1) | NO983480L (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11871745B2 (en) | 2021-03-08 | 2024-01-16 | Ka Shui Plastic Technology Co. Ltd. | Bacteria repellant polymer composites |
US12054594B2 (en) | 2021-03-08 | 2024-08-06 | Ka Shui Plastic Technology Co. Ltd. | Bacteria repellant polymer composites |
US12134672B2 (en) | 2021-02-03 | 2024-11-05 | Ka Shui Plastic Technology Co. Ltd. | Bacteria repellant polymer composites |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10040266A1 (en) * | 2000-08-17 | 2002-03-07 | Rehau Ag & Co | Device for use in dialysis |
US6743439B1 (en) | 2001-06-27 | 2004-06-01 | Alcon, Inc. | Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride |
TWI836373B (en) | 2010-07-30 | 2024-03-21 | 瑞士商愛爾康公司 | Hydrated contact lens |
CA2851668C (en) | 2011-10-12 | 2016-08-16 | Novartis Ag | Method for making uv-absorbing ophthalmic lenses by coating |
SG11201504763UA (en) | 2012-12-17 | 2015-07-30 | Novartis Ag | Method for making improved uv-absorbing ophthalmic lenses |
CA3082085A1 (en) | 2017-12-13 | 2019-06-20 | Alcon Inc. | Disposable water gradient contact lenses compatible with multi-purpose lens care solution |
-
1997
- 1997-07-29 DE DE1997132587 patent/DE19732587A1/en not_active Withdrawn
-
1998
- 1998-06-12 EP EP19980110790 patent/EP0894504A2/en not_active Withdrawn
- 1998-07-27 CA CA 2244049 patent/CA2244049A1/en not_active Abandoned
- 1998-07-28 NO NO983480A patent/NO983480L/en not_active Application Discontinuation
- 1998-07-28 JP JP10212593A patent/JPH11116640A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12134672B2 (en) | 2021-02-03 | 2024-11-05 | Ka Shui Plastic Technology Co. Ltd. | Bacteria repellant polymer composites |
US11871745B2 (en) | 2021-03-08 | 2024-01-16 | Ka Shui Plastic Technology Co. Ltd. | Bacteria repellant polymer composites |
US12054594B2 (en) | 2021-03-08 | 2024-08-06 | Ka Shui Plastic Technology Co. Ltd. | Bacteria repellant polymer composites |
Also Published As
Publication number | Publication date |
---|---|
NO983480D0 (en) | 1998-07-28 |
NO983480L (en) | 1999-02-01 |
JPH11116640A (en) | 1999-04-27 |
DE19732587A1 (en) | 1999-02-04 |
EP0894504A2 (en) | 1999-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2252597C (en) | Non-thrombogenic and anti-thrombogenic polymers | |
DK169552B1 (en) | Method of forming an improved hydrophilic surface layer on a substrate of a polymeric material and medical object provided with such hydrophilic surface layer | |
US6248811B1 (en) | Bioactive surface coating | |
US5688855A (en) | Thin film hydrophilic coatings | |
AU2010339654B2 (en) | Coating agents and coated articles | |
US5453467A (en) | Polymer treatments | |
CA3105562C (en) | Bioactive coatings | |
EP0394496B1 (en) | Glycoside derivatives, polymers containing glycoside derivatives, process for their preparation, and use of said polymers | |
EP0714417B1 (en) | Polymer surface coatings | |
US9567357B2 (en) | Biocompatible, biomimetic ampholyte materials | |
EP1206946B1 (en) | Medical materials and process for producing the same | |
CA2244049A1 (en) | Bioactive coating with a low-friction surface | |
US5242995A (en) | Perfluorocarbon-grafted polyurethane with improved blood compatibility and process for their preparation | |
CN111420129B (en) | Preparation method of degradable polycarbonate coating for reducing corrosion rate of medical magnesium-based materials | |
CA2241483A1 (en) | Bioactive coating of surfaces by using cross-linking agents | |
EP3723839B1 (en) | Polyurea copolymer coating compositions and methods | |
WO2018061916A1 (en) | Copolymer and medical material using same | |
WO1996035722A1 (en) | Process to activate sulfated polysaccharides | |
US7034061B1 (en) | Non-thrombogenic and anti-thrombogenic polymers | |
Lu et al. | Grafting of a novel phosphorylcholine-containing vinyl monomer onto poly-carbonateurethane surfaces by ultraviolet radiation grafting polymerization | |
US5173554A (en) | Glycoside derivatives, polymers containing glycoside derivatives, process for their preparation, and use of said polymers | |
TWI840294B (en) | Zwitterionic polymer, method of making the same and antibacterial coating composition including the same | |
CA2226133A1 (en) | Bioactive surface coating | |
US10251981B2 (en) | Coating layer, coating solution, method for forming coating layer, and method for producing medical tool | |
JP3203351B2 (en) | Antithrombotic material and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |